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ABSTRACT
Treatment of alkenyldicyclohexylboranes with 1-lithio-5-butyl-3,4-nonadien-1-yne,
derived from 5-butyl-3,4-nonadien-1-yne, followed by trimethyltin chloride and acetic acid
furnished the corresponding o-isotoluenes in a single operation.  The reaction proceeded through
an initial formation of (Z)-diene-allenes, which underwent facile eletrocyclizations to produce 
o-isotoluenes.
Treatment of allenyldicyclohexylborane with 1-lithio-5,5-pentamethylene-3,4-pentadien-
1-yne produced the organoborate complex, which on further treatment with trimethyltin chloride
furnished a (Z)-1,2,4,6,7-octapentaene (enediallene) derivative in situ.  The subsequent
electrocyclic reaction then generated the corresponding o-quinodimethane attached with a
dicyclohexylboryl group and a trimethyltin group.  The resulting o-quinodimethane then
underwent a [1,5]-sigmatropic hydrogen shift, and on subsequent oxidative workup and
protonation gave the 4-(1-cyclohexenyl)-3-methylphenol (51%).  The presence of a boron group
and a tin group in the benzene ring of a reaction intermediate also provides handles to allow their
transformations to an allyl substituent and an iodo substituent to produce a tetrasubstituted
benzene ring (30%) in a single operation.  Attempts to capture the o-quinodimethane
intermediate with a carbon–carbon double bond intramolecularly afforded a tricyclic phenol in
low yield (6%). A number of other o-quinodimethanes were also generated by using different
combinations of organoboranes and 1-lithio-1-alkynes.
6H-Indolo[2,3-b]quinolines were synthesized from N-[2-(1-alkynyl)phenyl]-N-
phenylcarbodiimides via a thermally-induced biradical-forming reaction.  The Pd-catalyzed
cross-coupling reaction between methyl 2-iodobenzoate  and 1-alkynes furnished methyl 2-(1-
xvi
alkynyl)benzoates, which were hydrolyzed to afford the corresponding benzoic acids.  Treatment
of the benzoic acids with diphenyl phosphorazidate  produced the 2-(1-alkynyl)phenyl
isocyanates.  The subsequent aza-Wittig reactions with the iminophosphorane, derived from
aniline and Ph3PBr2 then gave the benzoenynyl carbodiimides.  Thermolysis of the benzoenynyl
carbodiimides in refluxing p-xylene at 138 C produced the corresponding 6H-indolo[2,3-
b]quinolines.  Similarly, thermolysis of the carbodiimides having two benzoenynyl carbodiimide
moieties produced compounds having two indoloquinoline units connected at the 11 and the 11
positions with either a three-carbon or a five-carbon tether.  By using 1,4-phenylene diisocyanate
for the aza-Wittig reaction with two equiv of the iminophosphorane followed by thermolysis
furnished a compound (66%) having two indoloquinoline units incorporated in the seven fused
rings. 
The synthetic pathway to the 6H-indolo[2,3-b]quinolines was successfully adopted for
preparation of the 5-aza anologues of ellipticine, a naturally occuring alkaloid having potent anti-
cancer properties.  This approach, which constructs the B and the C rings in one step, is an
efficient route in producing the aza analogues of the ellipticine family of antitumor alkaloids.    
11 2 3
1 5
36 oC
+
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PART I
SYNTHESIS OF 5-METHYLENE-1,3-CYCLOHEXADIENES 
(o-ISOTOLUENES) 
VIA ELECTROCYCLIZATION OF (4Z)-1,2,4,6-HEPTATETRAENES
1. Introduction
o-Isotoluene, 5-methylene-1,3-cyclohexadiene (1) is one of the three alicyclic isomers of
toluene which can be written by shifting the hydrogen from the methyl group to the ortho-, para-
and meta- carbon atoms as shown in 1, 2 and 3, respectively.1  Compared to toluene, the o-
isotoluene 1 possesses an additional 24 kcal/mol in energy,2 which is mainly responsible for its
unusual chemical reactivity.  The o-isotoluene 1 is easily dimerized under mild thermal
conditions via the concerted ene reactions to the corresponding dimers 4 and 5 (75% yield, 
21
PhCH3
Ph
Ph Ph Ph
9
7 8
PhCH2OOH
+
hv
or H+
PhCH2C(CN)2CH(CN)2
O2
10
6
PhCH=CH2(NC)2C=C(CN)2
80 oC
Scheme 1
4:5 = 2:1).3  Because of the formation of an aromatic system during dimerization of 1, the rate of
the ene reaction was greatly increased.4  Treatment of 1 with tetracyanoethylene (TCNE)
produced the corresponding ene adduct 6.5  Similarly,  reaction of 1 with styrene at 80 C gave    
1,2-diphenylpropane (7) and 1,3-diphenypropane (8) in 90% total yield with a 3:1 ratio     
(Scheme 1).6b The o-isotoluene 1 is also sensitive to acid and oxygen, being rapidly converted to
toluene (9)6b and benzyl hydroperoxide (10),6 respectively.
The high reactivities of 1 and its derivatives put severe constraints on possible synthetic
methods for these fascinating compounds.  However, there were only a few synthetic methods in
the literature that provided solutions to accomplish this difficult task.
1.1. Synthesis of o-Isotoluene by Thermolysis
o-Isotoluene could be prepared by thermolysis of its suitable precursors.  Bailey reported
the first synthesis of o-isotoluene by pyrolysis of the ester 11 in 1962 (Scheme 2).7a  The      
5-methylene-1,3-cyclohexadiene (1) was separated by a preparative gas-phase chromatographic
column in low yield.  The compound was quite stable at dry ice temperature, in contrast the pure
3COOH COOH
O
OH3CO
CH3CH2
11 1 9
1 : 9
Scheme 2
+
80 oC
96%
1) LiAlH4 (85%)
  2)CH3OCCl (41%)
+
340-360 oC
in CH3OH
O
OO
O
OO
OO
Scheme 3
12 13
e-
45%
400 oC
65%
1
liquid isomerized to toluene rapidly at room temperature.
Kopecky 5b reported a similar thermolysis of 13.  In his approach, 13 was generated by
electrolysis of 12 (Scheme 3).
In 1979, Pryor et al. developed an alternative route to o-isotoluene (Scheme 4).7b  The
pyrolysis of the neat ketone 14 followed by GLC purification gave 1.  This methodology gave a
fivefold increase in yield compared to the Bailey’s route and it avoided the electrolysis step of 
41
Cl Cl
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MeO OMe
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Cl
Cl
Cl
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THF
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60%
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Scheme 4
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14
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Cl
Cl
Cl
Cl
H2C C CH2
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+
1) LiAlH4
2) TsCl 48%
minor
+
15 200 oC
1Scheme 5
Kopecky’s approach.
The o-isotoluene also can be obtained from thermolysis of its isomers.  Hasselmann
reported that thermolysis of 5-methylenebicyclo[2.2.0]hex-2-ene (15), a bicyclic isomer of
toluene, afforded the o-isotoluene 1 (Scheme 5).5a
51Scheme 6
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1.2. Synthesis of o-Isotoluenes by Electrocyclization of Diene-Allenes
Alternatively, a facile electrocyclization of the transient (Z)-1,2,4,6-heptatetraene (diene-
allene) has also been shown to produce o-isotoluene 1.8  Brinker and coworkers used a carbene
rearrangement reaction to furnish the diene-allene 16.  The (Z)-diene-allene 16 then underwent
cyclization to produce 1.  However, many by-products also were formed and it was difficult to
separate 1 from the mixture (Scheme 6).
Our group recently reported a simple and versatile route to (Z)-diene-allenes.8b This
approach offers a practical synthesis of o-isotoluenes.  Therefore, condensation of 4-methyl-2,3-
pentadienal with -(trimethylsilyl)allylboranes afforded the hydroxyallylsilanes 17.  Treatment of
17 with KH gave the corresponding o-isotoluenes 19 (Scheme 7).  Apparently, the initially
formed diene-allene 18 underwent a facile electrocyclic reaction (<1 h, 25 C), as observed 
previously for compounds with similar chemical structures,8a,9 to afford 19.  It was noteworthy
6C
R1
R1
Li
C
R
R1
R1
Me3Sn
R22B
Me3Sn
R22B R
R1
R1
R
R1
R1
+ R22B
RMe3SnCl
Scheme 8
22
21 20
that the central double bond of 18 must have the Z geometry in order to allow the following six-
electron disrotatory electrocyclization reaction to occur.  Surprisingly, o-isotoluenes 19 survived
in the presence of KH and KOSiMe3, without tautomerization (< 2 %) to the corresponding much
more stable benzene derivatives.  These o-isotoluenes are thermally stable and could be purified
by distillation under reduced pressure at 35 C. 
2. Research Objective
The objective of this research project is to develop a practical synthetic route to (Z)-diene-
allenes 22 for cyclizations to o-isotoluenes.  The synthetic strategy involves treatment of
alkenyldicyclohexylborane 20 with 1-lithio-3,4-pentadiene-1-ynes 21 to form the corresponding
organoborate complexes followed by exposure to tributyltin chloride to promote a selective
migration of the alkenyl group from the boron atom to the adjacent acetylenic carbon atom to
furnish the (Z)-diene-allenes 22 (Scheme 8).
3. Results and Discussion
It was previously reported by Zweifel  et al.9 that treatment of alkenyldicyclohexylboranes
7B
R
Bu3SnCl
Bu3Sn
B
R1
R
CH3CO2H
Li+
R
BH
B
R
R1Li
R1
R1
R
25
23 24 26
27
28
Scheme 9
24,  readily prepared from terminal alkynes 23 and dicyclohexylborane, with 1-lithio-1-alkynes
25 provided 1-alkynylalkenyldicyclohexylborates 26 (Scheme 9).  Exposure of 26 to tributyltin
chloride promoted a selective migration of the alkenyl group from the boron atom to the adjacent
acetylenic carbon atom to furnish 27, which on treatment with acetic acid was converted to the
dienes 28 with high geometric purity.                
We envisioned that the reaction sequence outlined in Scheme 10 could be easily adopted
for the synthesis of (Z)-diene-allenes 32 as transient intermediates toward o-isotoluenes (Scheme
10) by using the readily available 3,4-pentadien-1-yne10 to produce 1-lithio-3,4-pentadien-1-yne
(30) for the subsequent formation of the organoborate complexes. 
8B R
C BuBu
Li B
C
Bu
Bu
R
Me3SnCl
C
R
Bu
Bu
Me3Sn
B
Me3Sn
B R
Bu
Bu
R
Bu
BuCH3CO2H
Li+
29
31
32 33
34-40
RBH2 +    BH3  SMe2
Cl
30
THF
0 oC
H
Me3Sn
Scheme 10
Indeed, this synthetic route was found to be successful for the preparation of a variety of
o-isotoluenes.  Treatment of borane-dimethylsulfide with 2 equiv. of cyclohexene produced
dicyclohexylborane as a white slurry.11  Hydroboration of a terminal alkyne with
dicyclohexylborane then furnished the alkenyldicyclohexylboranes 29.  Subsequent treatment of
29 with the lithium acetylide 30 gave the organoborate complexes 31.  Trimethyltin chloride then
induced the migration of the alkenyl group to the adjacent acetylenic carbon, giving rise to the
diene-allenes 32.  The electrocyclization of the diene-allenes 32 to 33 were generally very
9O
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17%
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34
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facile,12 giving rise to the o-isotoluenes 34-40 after the treatment of 33 with acetic acid.  Unlike
the parent compound 1 without an R group on the six-membered ring, the o-isotoluenes 34 to 40
(Table 1) having an R group on the ring were stable to oxygen and could be isolated and purified
by column chromatography as observed previously.8b
However, in the presence of a sterically demanding tert-butyl group as the R group, the
rate of electrocyclization was significantly reduced, allowing isolation of the diene-allene 41a
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(41%) and 41b13 (35%) after treatment with acetic acid.  On heating in CDCl3 at 60 C for 96 h (t
½ = ca. 12 h), 41b was smoothly converted to the o-isotoluene 42b in 91% isolated yield (eq 1).13
The conjugated allenyne 48 was synthesized according to the reported procedure.10  Thus
treatment of 1-hexyne with n-BuLi in THF followed by the addition of paraformaldehyde in THF
produced 2-heptyn-1-ol (44) in 90% yield (Scheme 11).  Sequential treatment of 44 with n-BuLi, 
p-toluenesulfonyl chloride in THF followed by a solution of n-butylmagnesium chloride and
CuBr•LiBr afforded the disubstituted allene 45 in 83% yield.14  The subsequent coupling with 1-
iodo-2-(trimethylsilyl)acetylene (46)15 followed by desilylation then produced the allenyne 48 in
90% yield.
 
11
C C
SiMe3
Me3Si H
Br DMF,CuBr
      45 oC
(2)
Alternatively, allenynes were also prepared by coupling the bromoallenes with
trimethylsilyacetylene in the presence of copper (I) bromide (eq 2).  This route was also used in
our group for the synthesis of allenynes. 
4. Conclusion
We have successfully developed a novel synthetic route to the o-isotoluene derivatives
under mild conditions.  The use of a suitable organoborates to allow a one-step conversion to the
(Z)-diene-allenes followed by a facile electrocyclization to the o-isotoluenes is an especially
attractive feature.  This synthetic route is also very versatile, allowing easy access to o-
isotoluenes with diverse structures. 
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PART II
GENERATION OF o-QUINODIMETHANES VIA THE ELECTROCYCLIC
REACTION OF (4Z)-1,2,4,6,7-OCTAPENTAENES DERIVED FROM THE
ORGANOBORATE COMPLEXES AND THEIR SUBSEQUENT REACTIONS
1. Introduction
o-Quinodimethane 49, also known as o-xylylene, has been used extensively as a reactive
intermediate in the synthesis of alkaloids, steroids and terpenes.16  It was first recognized by 
Cava and Napier in 1957 as a useful synthetic intermediate.  Later, Cava et al. generated the
parent o-quinodimethane by thermal elimination of sulfur dioxide from the sulfone 50, it was
trapped  with maleic anhydride to form the Diels-Alder adduct.17  Since then, many synthetic
routes to o-quinodimethanes have been developed.
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2. Synthetic Methods for o-Quinodimethanes
2.1. 1,4-Elinination of ,'-Disubstituted o-Xylenes
Many synthetic routes to o-quinodimethanes have been developed.  Among them, the 1,4-
elimination reactions of the ,'-disubstituted o-xylenes as shown in Schemes 12 and 13, are  the
most versatile methods because of the readily availability of the starting materials.  For example,
treatment of 51 with tetrabutylammonium fluoride (TBAF) in refluxing acetonitrile induced a
1,4-elimination to form the o-quinodimethane 53 having the E geometry, which then underwent
an intramolecular Diels-Alder reaction to furnish 54 having the trans ring junction (Scheme
12).18  This synthetic route provides an efficient pathway to many polycyclic systems. 
Alternatively, thermolysis of the sulfone 52 at 210 C promotes the extrusion of sulfur dioxide
which leads to 53 and consequently 54 (trans:cis = 5:1) in 65% yield.19
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49
heat
For the -substituted o-quinodimethanes having a (Z)-allylic hydrogen, the [1,5]
sigmatropic hydrogen shift is a facile process.20  Shechter et al. recently reported that treatment of
the sulfone 55 with TBAF produced both 57a (45%) and 57b (3.3%) (Scheme 13).20a
Presumably, the reaction proceeded through an initial 1,4-elimination to form the o-
quinodimethanes 56a as the major isomer and 56b as the minor isomer followed by a 
[1,5] sigmatropic hydrogen shift.  In many cases, the 1,4-elimination reactions are conducted at
ambient temperature.  In contrast, elevated temperature is needed to induce SO2-extrusion as
indicated in 54 as well as from related compounds.
2.2 Thermolysis of Benzocyclobutenes
The ready accessibility of benzocyclobutens together with their chemical inertness make
them a reliable and convenient source of o-quinodimethanes.  The transformation proceeds via 
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a thermally-allowed conrotatory electrocyclic ring opening.  Benzocyclobutenes having a
substituent on the 4-membered ring open outward to produce the sterically less hindered (E)-o-
quinodimethanes 59 in preference to the (Z)-isomer 60.  The substituted benzocyclobutenes also
undergo electrocyclic ring opening at a lower temperature than does the unsubstituted
benzocyclobutenes (Scheme 14).16a
2.3. Retro-Diels-Alder Reactions of Benzofused Heterocyclic Compounds
o-Quinodimethanes have also been generated from benzofused heterocyclic compounds
by retro-Diels-Alder reactions in which a small molecule of nitrogen, carbon dioxide, or sulfur
dioxide is lost by thermal or photochemical process.16i
It is also interesting to note that 62 has been reported to be in thermal equilibrium with
the cyclized benzocyclobutene.16d 
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Dittmer et al. reported a one-step synthesis of sultine 63 in good yield by treatment of
,'-dichloro-o-xylene with sodium hydroxymethane-sulfinate and sodium iodide in DMF.  This
new method for the generation of sultine 63 appears to be more convenient than the multistep
processes reported earlier.21
2.4. Photoenolization and Photorearrangement
The photochemical behavior of a series of o-alkyl substituted aromatic aldehydes and
ketones were investigated.  On irradiation they undergo photoenolization by a 1,5-hydrogen shift 
to form o-quinodimethanes.22,23  It is thought that the Z isomer returns rapidly to the starting
carbonyl compound by a [1,5] sigmatropic hydrogen shift, while the E isomer is relatively longer
lived.
The photolysis of o-alkylstyrenes has also been reported to produce o-quinodimethanes
via a [1,5] sigmatropic rearrangement.24
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2.5. Thermolysis of (Z)-1,2,4-Heptatrien-6-ynes
Recently, our group reported the thermolysis of (Z)-1,2,4-heptatrien-6-ynes to generate
,3-didehydrotoluene biradicals for subsequent decay to o-quinodimethanes (Scheme 15).20b,25
The thermally-induced cascade radical cyclization of the acyclic enyne-allene 64 to the fused
steroidal ring system was carried out in refluxing benzene for 2.5 h to furnish 68 having
predominantly the trans ring junction (trans:cis = 92:8).  Thermolysis of 64 promoted the Myers
cyclization to form the biradical 65.  Ring closure to form 66 is most likely the first event that
occurs following the Myers cycloaromatization reaction.  A subsequent 1,5-hydrogen shift then 
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produced the o-quinodimethane 67, which was in turn captured in an intramolecular Diels-Alder
reaction to give 68.
2.6. Electrocyclic Reaction of Enediallenes
An interesting but less studied route to o-quinodimethanes involves the electrocyclic
reaction of (4Z)-1,2,4,6,7-octapentaenes (enediallenes).  The parent (Z)-1,2,4,6,7-octapentaene
(70) was generated in situ by treatment of (Z)-4-octene-1,7-diyne (69) with potassium tert-
butoxide (Scheme 16).26  The subsequent electrocyclic reaction gave the parent 
o-quinodimethane 49, which then produced the spiro dimer 71 and the linear dimer 72. 
Isomerization from 70 to 49 must be a very facile process.  The corresponding benzofused27,28
and naphthofused27 analogues with a fused central carbon–carbon double bond isomerize rapidly
to 2,3-naphthoquinodimethane and 2,3-anthraquinodimethane, respectively, at ambient or sub-
ambient temperatures.  In addition, the electrocyclic reaction of (4Z)-1,2,4,6-heptatetraenes to 5-
methylene-1,3-cyclohexadienes (o-isotoluenes) is known to be vary facile.29  However, with 
the exception of the benzofused and the naphthofused analogues, other o-quinodimethanes have
19
not been prepared via the electrocyclic reaction of enediallenes.
In the previous chapter, a facile synthesis of o-isotoluenes via the electrocyclic reaction of
(4Z)-1,2,4,6-heptatetraenes was described (Scheme 10).29d  Treatment of
alkenyldicyclohexylboranes 29 with 1-lithio-3,4-pentadien-1-ynes, derived from lithiation of the
corresponding 3,4-pentadien-1-ynes with n-butyllithium, followed by trimethyltin chloride and
acetic acid furnished the o-isotoluenes 34-40.  Presumably, the reaction proceeds through the
formation of the organoborate complexes 31 followed by the trimethyltin chloride-induced
transformation to form 32 with the dicyclohexylboryl group and the trimethyltin group cis to each
other.30  The electrocyclic reaction of 32 then produces 33, after protonation with acetic acid, the
o-isotoluenes 34-40.  We envisioned that the reaction sequence outlined in Scheme 10 could be
adopted for the synthesis of enediallenes for subsequent conversion to o-quinodimethanes by
substitution of the alkenyldicyclohexylboranes 29 with allenyldicyclohexylboranes.
3. Research Objective
 Recently we reported a novel electrocyclization of diene-allenes to o-isotoluenes.  The
diene-allenes were synthesized via selective migration of the alkenyl group from the boron atom
to the adjacent acetylenic carbon atom of an organoborate complex.29d  We envisioned that an
allenyl group could also migrate from the borane atom to the adjacent acetylenic carbon atom of
an organoborate complex to afford enediallenes.  The subsequent electrocyclic reaction of
enediallenes could generate the o-quinodimethanes for further synthetic elaborations.
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4.  Results and discussion
Allenyldicyclohexylborane (74) was readily prepared by treatment of 
chlorodicyclohexylborane (73) with allenylmagnesium bromide (Scheme 17).  Sequential
treatment of 74 with 1-lithio-3,4-pentadien-1-yne 75, Me3SnCl, an alkaline H2O2 solution, and
acetic acid produced the phenol 80 in a single operation.  Apparently, trimethyltin chloride also
promoted a stereoselective migration of the allenyl group in 76 to the adjacent acetylenic carbon 
atom to afford the enediallene 77.  The electrocyclic reaction of 77 then generated the o-
quinodimethane 78, giving rise to 79 through a [1,5]-sigmatropic hydrogen shift.  Oxidative
workup followed by protonation with acetic acid then gave 80 in 51% yield.   
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The presence of a dicyclohexylboryl group and a trimethyltin group in 79 also affords
opportunities for other chemical transformations.  Treatment of 79 with n-butyllithium followed
by CuBrSMe2 and allyl bromide transformed the dicyclohexylboryl substituent to the allyl group,
presumably via an organocopper intermediate.30e-h  Further treatment of the resulting adduct with
I2  replaced the trimethyltin group with an iodo substituent30e-h to furnish 27 having a
tetrasubstituted benzene ring.
By using 30 to form the organoborate complex with 74, the o-quinodimethane 82 was
generated in situ (Scheme 6).  The subsequent [1,5]-sigmatropic hydrogen shift then furnished 83 
as a mixture of the E and the Z isomers (isomer ratio = 84:16) in 60% yield.  Whether the E
isomer or the Z isomer was produced as the predominant product has not been determined
definitively.  However, it is worth noting that the 1H NMR chemical shift of the alkenyl hydrogen
of the major product at  5.18 is 0.24 ppm upfield from that of the minor product at  5.42.  It
was reported previously that the 1H NMR chemical shift of the alkenyl hydrogen of the Z isomer
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of 1-(1-ethyl-1-propenyl)-2-methylbenzene at  5.35 is 0.24 ppm upfield from that of the E
isomer at  5.59.20a  The chemical shift correlation appears to suggest that the Z isomer of 83 is
the predominant product.  In any event, the E isomer is produced from the conformer 82a, while
the Z isomer is derived from the conformer 82b.  The relative severity of the A(1,2) allylic strain
in 82a versus the A(1,3) allylic strain31 in 82b determines the ratio of the resulting E and Z
isomers.  The preferential formation of the E isomer was reported previously in the system
leading to the formation of 1-(1-ethyl-1-propenyl)-2-methylbenzene.20a
  
It was possible to capture the o-quinodimethane in 85, derived from 74 and 84, with the
carbon–carbon double bond for the intramolecular Diels-Alder reaction to afford 86, which on
oxidative workup and protonation gave the tricyclic phenol 87 having predominantly the trans
ring junction (trans:cis > 10:1) (Scheme 19).  Unfortunately, the overall isolated yield of 87 is 
only 6%.  A small amount of 4-[(1E)-1,6-heptadienyl]-3-methylphenol (ca. 1%), presumably
derived from a [1,5]-sigmatropic hydrogen shift of the Z isomer of 85, was also produced.  The
effect of the boron and the tin substituents on the reactivity of the o-quinodimethane in 85 for the
intramolecular Diels-Alder reaction remains to be determined.
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An alternative pathway to the organoborate complexes for the subsequent formation of o-
quinodimethanes has also been developed.  Sequential treatment of 5-butyl-3,4-nonadien-1-yne 
(48) with n-butyllithium, B-methoxydicyclohexylborane, and 4/3 BF3OEt232 generated 88 in situ
(Scheme 20).  Further treatment of 88 with 1-lithio-1,2-heptadiene (89) gave the requisite 
organoborate complex 90 for transformation to the o-quinodimethane 92, leading to 93 and 
subsequently, after oxidative workup and protonation, the phenol 94 (61% yield, isomer ratio 
= 87:13).  Direct protonation of 93 with acetic acid furnished 95 in 57% yield.
By using the combination of 3,4,10-undecatrien-1-yne (96) and 89 to form the
organoborate complex 97, the phenols 105 (20%), 106 (10%), and 107 (15%) were obtained
(Scheme 21).  Apparently, 105 was produced via the intramolecular Diels-Alder reaction of 99 to
form 102, whereas 106 and 107 were produced via the [1,5]-sigmatropic hydrogen shift of 100
and 101 to form 103 and 104, respectively.
It is worth noting that the enediallene 98 is most likely a 1:1 mixture of the two 
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diastereomers 98a and 98b.  If the disrotatory motion of the six -electron system is also
required for the thermally-induced electrocyclic reactions of 98a and 98b, then 98a will be the 
precursor of 99 (eq 3) whereas 98b will be the precursor of both 100 and 101 (eq 4).32  The fact
that substantial amounts of 106 and 107 (combined yield = 25%) were produced appears to
suggest that the stereoelectronic requirement for the electrocyclic reaction dictates the
transformation of 98b to the sterically less favorable 100 and 101 with one of the exocyclic 
double bonds having the Z geometry.  Otherwise, one would expect a preferential formation of 
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+ +
99 with both of the exocyclic double bonds having the E geometry.  However, the possibility of
producing 99–101 from 98 via a biradical pathway without the requirement of an initial 
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disrotatory motion (Scheme 22) could not be ruled out.  A one-step intramolecular ene reaction
of 98 could also produce 103 and 104 directly.34
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5.  Conclusions
A new synthetic pathway to (4Z)-1,2,4,6,7-octapentaenes as precursors of o-
quinodimethanes has been developed.  The ability to generate enediallenes with high geometric
purity via the corresponding organoborate complexes in a single operation is an especially
attractive feature.  The process is very flexible, allowing easy assembly of various readily
available fragments to produce the requisite organoborate complexes.  The presence of the boron
and the tin substituents in the cyclized adducts also affords opportunities to introduce other
functional groups onto the benzene ring.     
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PART III
BIRADICALS FROM THERMOLYSIS OF N-[2-(1-ALKYNYL)PHENYL]-
N-PHENYLCARBODIIMIDES AND THEIR SUBSEQUENT
TRANSFORMATIONS TO 6H-INDOLO[2,3-b]QUINOLINES
1.Introduction
Since the discovery of the enediyne antitumor antibiotics,41 the chemistry of biradicals
have received great attention.  The Bergman cyclization of (Z)-3-hexene-1,5-diynes (enediynes)
to 1,4-didehydrobenzene biradicals (eq 5),42  the Myers cyclization of (Z)-1,2,4-heptatrien-6-ynes
(enyne–allenes) to ,3-didehydrotoluene biradicals (eq 6),43 and the Moore cyclization of 
enyne–ketenes (eq 7)44 to a phenoxy biradical species have been extensively studied.  However, 
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the biradical-forming reactions involving other heteroatoms in the conjugated systems are rare.45 
Our group recently reported the use of iminophosphoranes 109, readily prepared from treatment
of 2-(1-alkynyl)anilines 108 with dibromotriphenylphosphorane (Ph3PBr2), for the aza-Wittig
reaction with diphenylketene to produce N-[2-(1-alkynyl)phenyl]ketenimines 110 (Scheme 23).46
The ketenimines 110 then were converted to the quinolines 112 and/or the 
5H-benzo[b]carbazoles 115 depending on the nature of the substituent at the acetylenic terminus
30
under mild thermal conditions.
In the presence of an excess of 1,4-cyclohexadiene (1,4-CHD) as a hydrogen-atom donor,
110a (R = H) was converted to the quinoline 112a (t1/2 = 0.37 h at 22 C) in 49% yield. 
Apparently, the reaction proceeds through an initial cycloaromatization reaction to form the
biradical 111a followed by hydrogen-atom abstraction from 1,4-CHD.  The transformation from
110a to 111a represents a new example of a growing list of the thermally-induced biradical-
forming cycloaromatization reactions. The ability to produce 111a from 110a demonstrates the
feasibility of placing a nitrogen atom in the conjugated system for the generation of biradicals
under mild thermal conditions and provides a new avenue for the design of novel DNA-cleaving
agents.47
Interestingly, when 110b (R = SiMe3) was heated under refluxing benzene, the
benzocarbazole 115b was produced exclusively (t1/2 = 0.89 h at 72 C).  Presumably, the reaction
proceeded through a different cascade sequence involving an initial formation of a five-
membered ring to produce biradical 113b followed by an intramolecular radical-radical
combination to form 114b and a subsequent tautomerization to furnish 115b.  While a one-step
intramolecular Diels-Alder reaction of 110b could also produce 114b as reported previously in
several analogous systems,48 the presence of a sterically demanding trimethylsilyl group at the
acetylenic terminus makes the concerted process unlikely to occur under mild thermal conditions. 
The reaction was directed toward 115b presumably because of the emergence of a severe non-
bonded steric interaction in 111b (R = SiMe3)49 and the ability of the trimethylsilyl group in
stabilizing an adjacent radical site in 113b.50  Such a change of the reaction pathway was also
observed in a similar study51 and in several analogous cases of ring closures of enyne–allenes49,52
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and enyne–ketenes.53  Treatment of 115b with 1 N HCl at 40 C for one hour produced the
desilylated adduct 115a (>81% yield).  It is worth noting that 115a could not be obtained from
110a directly.  With the ketenimine 110d (R = Pr), both the quinoline 112d (58%) and the
benzocarbazole 115d (33%) were produced.  In the cases of 110e (R = tert-Bu) and 110f (R =
Ph), the benzocarbazoles 115e and 115f were produced exclusively.  The presence of a sterically
demanding tert-butyl group at the acetylenic terminus of 110e makes the formation of 114e via
the concerted intramolecular Diels-Alder reaction unlikely.   
A similar study was also reported by Schmittel, Engels, and coworkers recently (Schemes
24 and 25).51  They converted the amides 116 and 118 to the enyne-ketenimines,
leading to quinolines 117 and benzocarbazoles 119.  
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Recently, there has been a surge of interest in developing new synthetic pathways to 6H-
indolo[2,3-b]quinolines48b,54 because several members of this group of compounds have been
found to possess interesting biological activities.55 Molina et al. reported an intramolecular [4+2]
cycloaddition of C=C-conjugated carbodiimdes, prepared by the treatment of the
iminophosphorane 120 with phenyl isocyanate (Scheme 26) to afford the indolo[2,3-b]quinoline
121.48b,54a
Saito’s group also reported a similar approach toward the synthesis of pyrido[2,3-b]indole
and indolo[2,3-b]quinolines via intramolecular Diels-Alder reactions of conjugated
carbodiimides (Scheme 27).54b-c
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Very recently, Schmittel et al. reported a synthetic strategy (Scheme 28)56 similar to our
work.  His group prepared 6H-indolo[2,3-b]quinolines via thermally-induced biradical
cyclizations of enyne-carbodiimides generated from thioureas.
A logical extension of our recent work involves replacing the ketenimine moiety in 110 
with other heterocumulenes.  Carbodiimide appears to be an excellent candidate for such a
substitution.  Our group recently reported57 the use of N-[2-(1-alkynyl)phenyl]-N-
phenylcarbodiimides 122 to produce biradicals and their subsequent transformations to 2-
(phenylamino)quinoline (124a) and 6H-indolo[2,3-b]quinolines 127 (Scheme 29).58  It was
interesting to learn that carbodiimide 122a had already been prepared previously by treatment of
iminophosphorane 109a (R = H) with phenyl isocyanate.59  Thermolysis of 122a in toluene at
160 C in a sealed tube furnished 2-(phenylamino)quinoline (124a, 40%) and the parent 6H-
indolo[2,3-b]quinoline (127a, 19%).59  Our group was able to reproduce similar results by 
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     92%
heating 122a, isolated in 83% yield from treatment of 109a with phenyl isocyanate, in -
terpinene at 138 C to afford 124a (49%) and 127a (16%).  Apparently, 124a was produced via
the biradical 123a followed by hydrogen-atom abstraction from -terpinene.  A two-step
biradical pathway through 125a or a one-step intramolecular Diels-Alder reaction could furnish
126a, which then underwent tautomerization to give 127a.  Several analogues examples in which
a carbon-carbon double bond replaces the triple bond in 122 for the intramolecular Diels-Alder
reaction have been reported.48b,54  The indoloquinoline 127a was used as an immediate precursor
for the synthesis of a naturally occurring alkaloid, 5-methyl-5H-indolo[2,3-b]quinoline (128a) 
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127a
 or 127c
(eq 8),55,59 which was isolated from the roots of the West African plant Cryptolepis
sanguinolenta60 and was found to possess interesting biological activities.55
The reaction sequence outlined in Scheme 29 could provide an efficient route to the
indoloquinoline 127a if the competing pathway toward the quinoline 124a could be suppressed. 
The result with 110b suggests that a trimethylsilyl group at the acetylenic terminus could serve as
a surrogate for the hydrogen atom in directing the reaction toward the indoloquinoline 127b.  A
subsequent protodesilylation reaction could lead to 127a.  Indeed, thermolysis of 122b, obtained
in 71% from 109b and phenyl isocyanate, in refluxing p-xylene at 138 C produced 127b in 86%
yield.  Similarly, heating the reaction mixture of 109b and phenyl isocyanate in refluxing p-
xylene without isolation of 122b also gave 127b (61%) in a single operation.  Treatment of 127b
with 6 N NaOH in refluxing ethanol for 12 h then furnished 127a in 92% yield.
When 122c was subjected to thermolysis in p-xylene at 138 C for 4 h, the
indoloquinoline 127c (77%) was produced exclusively, indicating a preferential formation of
126c for subsequent tautomerization to 127c.  The corresponding quinoline 124c (R = Me) was
not detected.  Direct thermolysis of the reaction mixture of 109c and phenyl isocyanate in
refluxing p-xylene without isolation of 122c also afforded 127c (59%) in a single operation.  It
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was reported that 127c could serve as the immediate precursor of 5,11-dimethyl-5H-indolo[2,3-
b]quinoline (128c) (eq 8), which was found to display a strong antibacterial, antimycotic, and
cytotoxic activity in vitro, as well as significant antitumor properties in vivo.55  
Similarly, when 122d was heated either in refluxing p-xylene or in -terpinene at 138 C,
the indoloquinoline 127d (89%) was produced exclusively, in sharp contrast to the ketenimine
110d (R = Pr) which furnished the quinoline 112d preferentially.  In addition, the carbodiimide
122d is thermally less labile than the ketenimine 110d, and a higher temperature is needed to
promote the reaction.  Treatment of 109d with phenyl isocyanate in refluxing p-xylene without
isolation of 122d also afforded 109d directly in a one-step operation in 72% yield.  With 122e
having a sterically very demanding tert-butyl group, thermolysis in refluxing p-xylene for 14 h
produced the indoloquinoline 127e (76%).  Again, the presence of a tert-butyl group at the
acetylenic terminus of 122e makes the formation of 126e via the concerted intramolecular Diels-
Alder reaction unlikely.  With a phenyl substituent at the acetylenic terminus of 122f, thermolysis
under refluxing benzene (80 C) for 4 h was sufficient to induce the transformation to 127f18 in
91% yield.  Direct thermolysis of the reaction mixture of 109f and phenyl isocyanate in refluxing
benzene without isolation of 122f also afforded 127f in 67% yield.
4-Methoxyphenyl isocyanate was also used for the aza-Wittig reaction with 109d and
109f.  Thermolysis of the reaction mixtures furnished the indoloquinolines 129d and 129f48b 
having a methoxy substituent at the C-2 position (eq 9).
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2. Results and Discussion
In order to further extend the synthetic applications of Scheme 29, an alternative pathway
to the carbodiimides 122 was also developed (Scheme 30).  The Pd-catalyzed cross-coupling 
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reaction between 130 and 1-alkynes furnished methyl 2-(1-alkynyl)benzoates 131, which were
hydrolyzed to afford 132.  Treatment of 132 with diphenyl phosphorazidate (DPPA)61 produced
2-(1-alkynyl)phenyl isocyanates 133.  The subsequent aza-Wittig reactions with the
iminophosphorane 13462 then gave 122d and 122f.  Thermolysis of the reaction mixtures of 133d
and 133f with 134 in refluxing p-xylene also produced the indoloquinolines 127d (50%) and
127f (55%), respectively.
It is straightforward to adopt the synthetic sequence outlined in Scheme 29 for the
preparation of 139a and 139b (Scheme 31) as potential bifunctional DNA intercalating agents.63  
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The use of the diacetylenes 135a and 135b for cross coupling with two equiv. of 2-iodoaniline 
eventually allowed the connection of the two indoloquinoline units in 139a and 139b with either
a three-carbon or a five-carbon tether at the 11 and the 11 positions.  The iminophosphoranes 
137a and 137b were generated in situ from treatment of 136a and 136b with two equiv. of
Ph3PBr2 for the subsequent aza-Wittig reaction with two equiv. of phenyl isocyanate, producing 
the carbodiimides 138a and 138b in 49% and 54% overall yield, respectively.  It was possible to
isolate the iminophosphoranes 137a (20%) and 137b (29%) by column chromatography (silica
gel) albeit significant decomposition occured on the column.  Treatment of the isolated 137a
with two equiv of phenyl isocyanate produced 138a in 72% yield.  Thermolysis of 138a and
138b in refluxing p-xylene then furnished 139a (74%) and 139b (77%), respectively.
Treatment of 1,4-phenylene diisocyanate with two equiv of 109g for the aza-Wittig
reaction produced 140 in situ, which on thermolysis in refluxing p-xylene furnished 144 (66%)
having two indoloquinoline units incorporated in the seven fused rings (Scheme 32).  It was also
possible to isolate 140 by column chromatography (silica gel) in 44% yield.  The presence of the
two n-octyl groups in 144 greatly enhances its solubility in organic solvents.
The structure assignment of 144 is based on high-resolution mass spectra, the 1H and 13C
NMR spectra, and the NOE studies.  The molecular ion was detected on a high-resolution mass
spectrometer (m/z = 582.3698).  The 1H and 13C NMR spectra showed the right number of signals
and pattern of multiplicity consistent with the structure of 144.  Interestingly, the 1H NMR
spectrum (Figure 1) exhibited two sets of signals with equal intensity at  4.00 (2 H, ddd, J =
12.9, 8.7, and 4.2 Hz) and 3.74 (2 H, dt, J = 13.4 and 8.0 Hz), indicating that the benzylic 
hydrogens are diastereotopic.  The benzylic hydrogens are diastereotopic because the fused ring 
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structure in 144 is helical due to nonbonded steric interactions of the two n-octyl groups.  This is
reminiscent of the structures of the 4,5-dimethylphenanthrenes, which have been shown to
possess a helical twist.64  The signals of the benzylic hydrogens in DMSO-d6 remained well
separated and exhibited no line broadening even at 110 C, indicating that the rate of the helix 
inversion is relatively slow on the NMR time scale even at 110 C.  A significant nuclear
Overhauser effect was observed between the doublet aromatic signal at  8.28 and the benzylic
signal at  4.00.  However, the nuclear Overhauser effect was negligible with the benzylic signal
at  3.74.  In addition, no NOE interaction between the singlet aromatic signal at  8.23 and the
two benzylic signals was observed.
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                  Figure 1. Partial 1H NMR Spectrum of the Indoloquinoline 144 in CDCl3.
The observation of two sets of benzylic signals and the lack of the NOE interaction with
the singlet aromatic signal at  8.23 preclude the cycloaromatized isomer 148 depicted in
Scheme 33 as the reaction product.  Because 148 has essentially a planar ring structure, one
would expect the 1H NMR signal of the benzylic hydrogens of 148 to be a simple triplet as in the
case of 127d.  Furthermore, one would also expect a strong NOE interaction between the
benzylic hydrogens and the singlet aromatic hydrogens.
The preferential formation of 144 is presumably because the rate of transformation from
141 to 143 (Scheme 32) is faster than that of tautomerization of 141 to 145 (Scheme 33).  
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145
Without a prior tautomerization, the biradical 142 has no choice but to cyclize to form 143,
producing 144 after two subsequent tautomerization reactions.  Had the intermediate 141
underwent a tautomerization reaction to form 145 prior to the second indoloquinoline formation,
one could have expected a preferential ring closure leading to 148 without nonbonded steric
interactions between the two n-octyl groups.  It is worth noting that the indoloquinoline 144
having an extended aromatic ring structure is potentially capable of intercalating DNA.65       
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3. Conclusions
Thermolysis of the carbodiimides 122 represents a new way of generating biradicals from
unsaturated molecules having two nitrogen atoms in the conjugated system.  The cascade
sequence outlined in Schemes 29 and 30 also provide an efficient pathways to 6H-indolo[2,3-
b]quinolines.  The possibility of placing a wide variety of substituents at various positions of the
6H-indolo[2,3-b]quinoline structure by selecting suitable fragments for assembly is an especially
attractive feature of this synthetic route. 
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PART IV
AN EFFICIENT SYNTHESIS OF 5-AZA ANALOGUES OF ELLIPTICINE
1. Introduction
1. 1. Ellipticine and Its Analogues
Several alkaloids containing the indolo structure as part of their polycyclic frameworks
have been found to show potent biological activities.  Over the past twenty years, members of the
6H-pyrido[4,3-b]carbazole class of alkaloids, particularly ellipticine (149, R = H) and 9-
methoxyellipticine (150, R = OCH3) and their derivatives, have been the subject of intense
synthetic, biological and pharmacological studies.67  The natural plant alkaloid ellipticine was
first isolated in 1959 from the leaves of Ochrosia elliptica Labill (Apocynacae family), a plant
harvested in Florida.68  In 1967, the antitumor properties of ellipticine were revealed.69  It was
also found that 9-hydroxyellipticine is forty times more active than ellipticine on Leukaeuia L-
1210.70  Interests in ellipticine and ellipticine analogues as potential cancer chemotherapeutic
agents have promoted considerable efforts in search for new analogues with superior autitumor
activities.70  9-Hydroxy-2-methyl ellipticinium acetate 151 (9-HE) is one of several ellipticine
analogues shown to possess significant antitumor activities and, during phase II clinical use in
France, has been shown to elicit modest responses in patients with advanced breast cancers.71 
Recently, 9-methoxy-2-methyl-ellipticine acetate 152 has been shown to exhibit selective
cytotoxicity against a subpanel of human central nervous system (CNS) tumors when compared 
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with a broader panel of human tumor cells (in vitro).72  Anderson et al. reported that 9-methoxy-
2-methyl ellipticinium acetate 152 exerts anticancer effect without being transformed to 9-
hydroxy-2 methylellipticinium acetate.73
Recently, the National Cancer Institute (NCI) has screened and analyzed the anticancer
activity patterns of 112 ellipticine analogues using a hierachical clustering algorithm.74  These
compounds act by a combination of different mechanisms including DNA intercalation,
inhibition of topoisomerase II, alkylation of macrobiomolecules, and redox generation of
cytotoxic free radicals.75  The high affinity of ellipticine and its derivatives to DNA and its
intercalation between DNA base pair have long been considered the two main factors responsible
for their antitumour activities.  The strong cytotoxic activity of 9-HE, a biometabolite of
ellipticine, suggests that ellipticine is biometabolised to 9-HE prior to interacting with DNAs. 
The antitumoral activity of ellipticine or general pyridocarbazoles could be explained on the
basis of hypotheses which are related to DNA, RNAs and protein molecules as possible targets
for 9-HE.  These hypothesis are illustrated in Scheme 34.67c 
The significant anti-cancer activities of ellipticine and its analogues have promoted
considerable synthetic efforts in this area, and many synthetic approaches to the pyrido[4,3-
b]carbazole ring system have been described.67
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1. 2. Synthetic Routes Toward Ellipticine and Its Analogues
Since the first total synthesis of ellipticine by Woodward et al. in 1959,76  no less than 30
different routes to pyrido[4,3-b]carbazoles have been reported.  All the known synthetic
approaches are classified into four classes: the B-, C-, D- and (B+C)- type syntheses based on
which rings are generated.
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1. 2. 1. The B-Type Synthesis.
Miller77 and his colleagues described a general and regiospecific synthesis of
pyridocarbazole alkaloid.  This methodology keeps the isoquinoline (ring C and D) and benzene
(ring A) portions of the molecule separate until the latter stages of the synthesis and forms the
pyrole ring (B) in the last step by a nitrene insertion reaction (Scheme 35).  Acylation-alkylation 
of 2,5-dimethylacetanilide (153), prepared by acetylation of 2,5-dimethylaniline with 3-
chloropropionyl chloride, gave an aminoindanone, which was hydrolyzed to give 5-amino-4,7-
dimethylindan-1-one (154).  Bromination of 154 followed by protection of the amino group gave
155, which was reduced and eliminated to form the indene 156.  Hydrolysis of the acetamido
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group in 156 afforded 6-amino-7-bromo-5,8-dimethylisoquinoline (157) in 50% overall yield
from 153.  The Suzuki coupling of the aminobromoisoquinoline 157 with phenylboronic acid
yielded 158 in 99% yield.  The amine 158 was converted to 6-azido-5,8-dimethyl-7-
phenylisoquinoline (159) by diazotization followed by treatment with sodium azide.  The
azidophenylisoquinesline 159 through thermolysis in dodecane at 180 C afforded ellipticine as a
yellow solid in 96% yield.
Another B-type syntheses of potent anticancer 9-azaellipticine derivatives was reported
by Bisagni and co-worker (Scheme 36).78,55a  Treatment of 4-chloro-3-nitropyridine (160) with 6-
amino-5,8-dimethylisoquinoline (161) and HCl gave 162 in 29% yield.  Catalytic hydrogenation
of 162 (94%) followed by diazotization of the resulting amine furnished the triazole 163 (84%). 
The 9-azaellipticine 164 was obtained when 163 was heated at 320-340 C in paraffin oil (41%).
1. 2. 2. The C-Type Synthesis
There are  a large number of elegant synthetic efforts reported in the literature describing
the C-type synthesis of the ellipticine and its analogues.  In 1977, Bergman and Carlson79 
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developed a very efficient synthesis of ellipticine (149) (Scheme 37).  Acid-promoted
condensation of 2-ethylindole (165) with 3-acetylpyridine gave 166 (90%).  Alkylation of the
pyridine nitrogen with n-butyl bromide (100%) and rapid pyrolysis (>350 C, 5 min) of the
resulting pyridinium salt 167 gave ellipticine 149 in 72% yield, along with about 10% of the
pyrido[2,3-b]carbazole regioisomer 168.
Moody80 et al. developed a new concise synthesis of ellipticine via a Diels-Alder reaction
between a pyranoindolone and 3,4-pyridyne, generated in situ from thermolysis of 170. 
Treatment of triazene acid with Ac2O in the presence of BF3 •Et2O gave 1,4-dimethylpyrano[3,4-
b]indole-3-one (169).  A Diels-Alder reaction of 169 with 3,4-pyridyne (170) gave  ellipticine
149 (20%) together with an equal amount of the isoellipticine 171 (Scheme 38).
Recently, Gribble and coworkers81 developed a Diels-Alder approach to ellipticin
(Scheme 39).   Indole 172 was converted to 1-(phenylsulfonyl)indole (173) in 91% yield. 
Regiospecific lithiation of 173 at the C-2 position was achieved by treatment of LDA and the 
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resulting  174 was rapidly treated with pyridine anhydride.  This process produced a mixture of
175 and 176 in 78% yield and in a 92:8 ratio.  The major isomer 175, on hydrolysis with K2CO3
in MeOH followed by treatment with hot Ac2O, furnished the keto lactam 178.  This keto lactam,
on treatment with methyllithium (2 equiv), yielded a mixture of diols which on treatment with
NaBH4 gave the ellipticine 149 in 82% yield from 178 and 54% overall yield from indole (six
steps),  representing one of the most efficient synthesis of 149.
Very recently, Miki82 reported a simple and high yield synthesis of ellipticine.  Treatment
of N-benzylindole-2,3-dicarboxylic anhydride (183) with 3-bromo-4-pyridiyltitanium, a
derivative prepared from 3-bromo-4-lithiopyridine and ClTi(OPri)3 in THF, afforded the 2-
acylindole-3-carboxylic acid 184 in 86% yield.  Decarboxylation and debenzylation of 184 
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furnished 185.  Treatment of 185 with methylenetriphenylphosphorane for the Wittig reaction
followed by catalytic hydrogenation afforded 186.  Treatment of 186 with 1-
ethoxyethenyltributyltin in the presence of a palladium catalyst gave the corresponding
ethoxyvinyl derivative 187, which was converted to ellipticine in 87% yield by treatment with
10% hydrochloric acid in THF (Scheme 40).
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Finally, Kononova and Semenov83 reported the first synthesis of 5-azaellipticine by
cyclocondensation of the acetylpyridine 188 with oxindole in the presence of piperdine at 200 C
(Scheme 41).  The acetylpyridine 188 was prepared from 3-acetylpyridine in 7 steps in 3%
overall yield. 
1. 2. 3. The D-Type Synthesis
One of the most versatile routes to 6H-pyrido[4,3-b]carbazoles was first employed by
Cranwell and Saxton (Scheme 42).84  It is this approach that was employed in the commercial
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manufacture of 2-methyl-9-hydroxyellipticinium acetate (151) for the treatment of myleoblastic
leukemia, advanced breast cancer, and other solid tumors (Institute Pasteur brochure).  A large
number of procedures based on this general approach have been reported, including the Okay’s
synthesis85 of 5-demethylellipticine, the Schannon’s synthesis86 of hydroxyellipticines and the
Anderson’s approach73 of 9-substituted ellipticines and 2-methylellipticinium analogues.  In the
original procedure, ellipticine was synthesized from indole via 1,4-dimethylcarbazole (190).  The
Vilsmeier formylation generally gives the 3-carboxaldehyde as the major product.  Condensation
with aminoacetaldehyde acetal gives the imine acetal 191, which, using various methods, can be
cyclized to the ellipticine ring system (overall yield from indole ~1.5%).
1. 2. 4. The (B+C)-Type Synthesis
An elegant synthetic approach to ellipticine was reported by Differding and Ghosez,48a
employing an intramolecular Diels-Alder cycloaddition reaction of an acetylenic vinylketenimine
as a key step to construct the B and C rings of the ellipticine simultaneously (Scheme 43).  
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N-Methylpiperidone was transformed to the ester 192 by a Wittig-Horner reaction (75%). 
Treatment of 192 with LDA followed by quenching with NH4Cl yielded the ,-unsaturated ester 
(~100% crude yield), which was directly saponified (2 equiv of 1 N KOH, 2 h, 60 C) to the acid
193 (75%).  Conversion of 193 to the acid chloride followed by addition of o-
carbomethoxyacetylenic aniline gave the anilide 194 in 42% overall yield.  Treatment of 194
with Ph3P •Br2 and Et3N generated the vinylketenimine 195, which underwent an intramolecular
cycloaddition reaction to furnish 196 (50%).  Reduction of 196 by LAH-AlCl3 readily furnished
N-2-methyltetrahydroellipticine 197 (71%). 
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2. Result and Discussion
One of the problems encountered in using the naturally occurring antitumor alkaloid
ellipticine for clinical applications is its low solubility in water.  To overcome the limited water
solubility of ellipticine, several ellipticine analogues incorporated with polar groups on the N-2
nitrogen, such as 9-methoxy-2-methylellipticinium acetate 152, were prepared. We envision
that one way to increase the solubility is to replace the C-5 carbon with a nitrogen atom to
produce aza-ellipticine.  Only one precedent of such aza-ellipticine was reported previously
(Scheme 41).83  Our method for the synthesis of the indoloquinoline derivatives was readily
adopted for the preparation of these aza-ellipticine analogues.57 
The general features of the synthesis of 5-azallipticine analogues are outlined in a
retrosynthetically in Scheme 44.  The key step for the synthesis of 5-aza-ellipticine skeleton was
achieved by using the biradical cyclization reaction of the carbodimides 122 that had been 
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developed in our group.  The carbodiimids 122 were prepared by the aza-Wittig reaction of the
isocyanates and the iminophosphorane 199.  The requisite alkynylphenyl isocyanates 133 were
obtained either from the corresponding benzoic acids employing the Curtius-type rearrangement
or from the corresponding anilines by treatment with triphosgene.87  The benzoic acids were
obtained by hydrolysis of the corresponding esters which in turn was prepared by a Pd-catalyzed
cross-couping reaction with terminal alkynes.  The ylide 199 was obtained by treatment of 4-
aminopyridine (200) with Ph3P•Br2.
A complete outline of our synthetic pathway to the 5-aza-ellipticine and its analogues is
illustrated in Scheme 45.  Treatment of methyl 2-iodobenzoate (130) with a degassed solution 
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containing 1-alkynes, dichlorobis(triphenylphosphine)palladium, copper (I) iodide, and N,N-
diisopropylethylamine in DMF at room temperature for 24 h gave the cross-coupling product
methyl 2-(1-alkynyl)benzoates 131 in excellent yields.  The benzoates 131 were further
saponified (1 M NaOH, 12 h, 60 C) to afford the benzoic acids 132.  The hydrolysis reaction
went smoothly and gave excellent yields.  Treatment of the benzoic acids 132 with diphenyl
phosphorazidate (DPPA)61 via a modified Curtius rearrangement produced the 
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2-(1-alkynyl)phenyl isocyanates 133.  The subsequent aza-Wittig reaction with the
iminophosphorane 199 then gave the carbodiimides 201, which were used directly.  Thermolysis
of 201 then furnished the 5-aza-ellipticine and its analogues 204 (Table 2).  The transformation
from 201 to 204 can proceed either through a two-step biradical mechanism or a one-step
intramolecular Diels-Alder reaction to furnish 203, which then undergoes tautomerization to give
204. 
The iminophosphorane 205 was also allowed to react with the isocyanates 133, producing
209 as the major isomer and 212 as the minor isomer (Scheme 46).  The results are summerized
in Table 3. 
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The synthetic sequences outlined in Schemes 45 and 46 can also be adopted for the
synthesis of 9-methoxy-5-azaellipticine 218 and its analogues 219 and 220 (Scheme 47).  The
 9-methoxy-2-methylellipticinium acetate has been found to exhibit remarkable selectivities in
vitro against the NCI human CNS cancer subpanel71b and also has much improved water
solubility than ellipticine.  The commercially available methyl 4-methoxysalicylate (213) was
first converted to the triflate 214 by treatment with triflic anhydride in 98% yield.  The remaining
sequence resembles the procedure described in Scheme 45 and 46.  
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3. Conclusions
We have successfully extended the synthetic sequence for 6H-indolo[2,3-b]quinolines to
the synthesis of 5-aza ellipticine and its analogues.  This approach, which constructs the B and
the C ring in one step, provides an efficient route in producing the aza analogues of the ellipticine
family of antitumor alkaloids.   
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PART V
  EXPERIMENTAL SECTION
All reactions were conducted in oven-dried (120 C) glassware under a nitrogen
atmosphere.  Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from benzophenone
ketyl prior to use.  Chlorodicyclohexylborane (73, 1.0 M solution in hexanes), trimethyltin
chloride (1.0 M solution in THF), n-butyllithium (2.5 M solution in hexanes), CuBrSMe2,
BF3OEt2, propargyl bromide (80 weight % solution in toluene), dibromotriphenylphosphorane
(Ph3PBr2), phenyl isocyanate, 1,4-phenylene diisocyanate, diphenylphosphorazidate (DPPA),
Pd(PPh3)2Cl2, Pd(PPh3)4, p-xylene (anhydrous), N,N-dimethylformamide (DMF), and N,N-
diisopropylethylamine were purchased from Aldrich Chemical Co., and were used as received. 
2-Iodoaniline was purchased from Oakwood Products, Inc. and was used as received.  1-Alkynes
were obtained from Farchan Laboratories, Inc. and were used without further purification. 
Iminophosphoranes 137 were prepared according to the reported procedure.46,54a   Methyl 2-
iodobenzoate was purchased from Lancaster.  Allenylmagnesium bromide was prepared
according to the reported procedure.35  B-methoxydicyclohexylborane was prepared by treatment
of dicyclohexylborane with methanol.36  5,5-(Pentamethylene)-3,4-pentadien-1-yne and 5-butyl-
3,4-nonadien-1-yne (48) were prepared as reported previously.29d  Similarly, 3,4,10-undecatrien-
1-yne (96) was synthesized in 52% overall yield from cross–coupling of 1,2,8-nonatriene37 with
1-iodo-2-(trimethylsilyl)ethyne (69%) followed by desilylation (75%).  1,2-Heptadiene was
prepared as reported previously.38  Triethylamine was distilled from CaH2.  The anilines 136
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(86–93% yield) were prepared from 2-iodoaniline according to the reported procedures.46,66  
Melting points are uncorrected.  1H (270 MHz) and 13C (67.9 MHz) NMR spectra were recorded
in CDCl3 using CHCl3 (1H  7.26) or CDCl3 (13C  77.00) as internal standard unless otherwise
indicated.
6-Butyl-5-dibutylmethylene-1,3-cyclohexadiene (34).  The following procedure for the
synthesis of o-isotoluene 34 is representative.  To 1.5 mL of a 2.0 M solution of BH3•SMe2 (3.0
mmol) in 8.0 mL of THF under a nitrogen atmosphere was added 0.61 mL (0.492 g, 6.0 mmol)
of cyclohexene at 0 C.  After 30 min, a white slurry of dicyclohexylborane appeared.11  The
mixture was kept at 0 C for an additional 30 min before cooling to -15 C.  A solution of 0.246
g of 1-hexyne (3.0 mmol) in 3.0  mL of THF was then introduced.  After 2 h at 0 to 5 C, the
reaction mixture became homogeneous and was used immediately to form the organoborate
complex.  To a second flask containing 0.528 g of 48 (3.0 mmol) in 3.0 mL of THF at -25 C
was added 1.2 mL of a 2.5 M solution of n-butyllithium (3.0 mmol) in hexanes.  After 15 min at
_25 C, the resulting 1-lithio-5-butyl-3,4-nonadien-1-yne was introduced via cannula to the flask
containing (E)-1-hexenyldicyclohexylborane at -25 C. The reaction mixture was stirred at rt for
1 h before cooling to 0 C.  A solution of trimethyltin chloride (3.0 mL, 1.0 M, 3.0 mmol) in
THF was then introduced with a syringe.  After an additional 1 h at rt, 2.0 mL of glacial acetic
acid was added, and the mixture was heated to 50 C for 1 h before cooling to rt.  Methanol (5.0
mL), 6.3 mL of a 6 N NaOH solution, and 1.74 mL of 30% H2O2 were then introduced
sequentially, and the reaction mixture was heated to 50 C for 1 h.  The mixture was then
extracted with pentane (3 x 10 mL), and the combined organic layers were washed with water,
dried over MgSO4, and concentrated.  The residue was purified by column chromatography
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(silica gel/hexanes) to furnish 0.465 g (60%) of 34 as a light yellow liquid: IR (neat) 1636,
1466,1378, 735 cm-1, 1H  6.34 (1 H, d, J = 9.9 Hz), 5.94 (1 H, dd, J = 3.0 and 1.0 Hz), 5.93 (1
H, dd, J = 3.0 and 1.0 Hz), 5.72 (1 H, dt, J = 9.9 and 3.0 Hz), 3.23 (1 H, m), 2,2 (2 H, m), 2.07 (1
H, m), 1.95 (1 H, m), 1,5 (1 H, m), 1.3 (13 H, m), 0.92 (9 H, m); 13C  141.05, 132.82, 131.71,
124.76, 122.51, 121.09, 37.81, 37.46, 31.82, 31.66, 31.40, 30.90, 28.14, 23.22, 23.04, 23.02,
14.12, 14.09, 14.07; MS (m/z) 260 (M+), 203, 161, 147, 133, 119, 105, 91.
5-Dibutylmethylene-6-pentyl-1,3-cyclohexadiene (35).  The same procedure was repeated as
described for 34 except that 1-heptyne (0.350 g, 3.64 mmol) and 5-butyl-3,4-nonadien-1-yne
(0.64 g, 3.64 mmol) were used to afford 0.533 g (54%) of 35 as a light yellow liquid: IR (neat)
2934, 2858, 1466, 1377, 980, 734 cm-1; 1H  6.36 (1 H, d, J = 9.9 Hz), 5.95 (1 H, dd, J = 3.0 and
1.0 Hz), 5.73 (1 H, dt, J = 9.9 and 3.0 Hz), 3.25 (1 H, m), 2.30 (2 H, m), 2.08 (1 H, m), 1.95 (1
H, m), 1.56 (1 H, m), 1.31 (15 H, m), 0.92 (9 H, m); 13C  140.91, 132.76, 131.76, 124.70,
122.50, 121.10, 38.01, 37.48, 32.17, 31.81, 31.65, 31.38, 30.87, 25.53, 23.20, 22.99, 22.63,
14.04, 13.99, 13.91; MS (m/z) 274 (M+), 231, 203, 175, 147, 133, 91, 55.
5-Dibutylmethylene-6-isopropyl-1,3-cyclohexadiene (36).  The same procedure was repeated
as described for 34 except that 3-methyl-1-butyne (0.1362 g, 2.0 mmol) and 5-butyl-3.4-
nonadien-1-yne (0.1362 g, 2.0 mmol) were used to obtain 36 (0.187 g, 38%) as a colorless liquid:
IR (neat) 2956, 1465, 1378, 986, 755 cm-1; 1H  6.35 (1 H, d, J = 9.7 Hz), 6.01 (1 H, dd, J = 9.5
and 5.2 Hz), 5.84 (1 H, dd, J = 9.5 and 5.6 Hz), 5.66 (1 H, dd, J = 9.8 and 5.2 Hz), 3.18 (1 H, t, J
= 5.4 Hz), 2.27 (2 H, m), 2.02 (1 H, m), 1.89 (1 H, m), 1.64 (1 H, m), 1.35 (8 H, m), 0.904 (3 H,
d, J = 6.9 Hz), 0.901 (3 H, t, J = 6.7 Hz), 0.85 (3 H, d, J = 6.7 Hz); 13C  142.02, 131.36, 129.75,
125.80, 124.27, 121.19, 43.51, 36.63, 31.93, 31.79, 31.23, 30.77,  23.21, 23.06, 20.25, 17.35,
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14.10; MS (m/z) 246 (M+), 244, 229, 203, 187, 160, 147, 117, 91, 77, 55.
5-Dibutylmethylene-6-phenyl-1,3-cyclohexadiene (37).  The same procedure was repeated for
34 except that phenylacetylene (0.33 mL, 3.0 mmol) and 5-butyl-3,4-nonadien-1-yne (0.528 g,
3.0 mmol) were used to obtain 37 (0.135 g, 16%) as a light yellow liquid: IR (neat) 2956, 1599,
1451, 1378, 787, 762, 698 cm-1; 1H  7.25 (5 H, m), 6.53 (1 H, d, J = 9.7 Hz), 5.87 (2 H, m), 5.78
(1 H, dt, J = 9.7 and 4.4 Hz), 4.33 (1 H, d, J = 3.7 Hz), 2.19 (2 H, m), 1.99 (1 H, m), 1.80 (1 H,
m), 1.34 (4 H, m), 1.18 (4 H, m), 0.91 (3 H, t, J = 7.1 Hz), 0.77 (3 H, t, J = 7.1 Hz); 13C  146.34,
143.88, 132.41, 129.77, 128.59, 127.04, 126.18, 125.07, 120.92, 120.65, 44.59, 32.65, 31.68,
31.38, 30.22, 23.14, 23.06, 14.04, 13.96; MS (m/z) 280 (M+), 251, 223, 195, 167, 165, 128, 115,
91, 55.  
6-(1-Cyclohexenyl)-5-dibutylmethylene-1,3-cyclohexadiene (38).  The same procedure was
repeated as described for 34 except that 1-ethynylcyclohexene (0.212 g, 2.0 mmol) and 5-butyl-
3,4-nonadien-1-yne (0.352 g, 2.0 mmol) were used to furnish 38 (0.233 g, 41%) as a light yellow
liquid: IR (neat) 2929, 1682, 1462, 1377, 1260, 993, 755 cm-1; 1H  6.38 (1 H, d, J = 10.1 Hz),
5.91 (1 H, m) 5.67 (1 H, m), 5.49 (1 H, br s), 3.84 (1 H, d, J = 5.4 Hz), 2.3 - 2.1 (4 H, m), 2.0 (4
H, m), 1.6 - 1.2 (12 H, m), 0.9 (6 H. m); 13C  143.28, 140.80, 131.39, 128.61, 125.31,121.85,
120.94, 120.53, 47.37, 32.43, 31.75, 31.61, 31.47, 30.83, 25.53, 24.44, 23.31, 23.08, 22.52,
14.13, 14.04;  MS (m/z) 284 (M+), 242, 227, 199, 171, 159, 129, 117, 91, 55.
5-Dibutylmethlene-6-(methoxymethyl)-1,3-cyclohexadiene (39).  The same procedure was
repeated as described for 34 except that methyl propargyl ether (0.140 g, 2.0 mmol) and 5-butyl-
3,4-nonadien-1-yne (0.352 g, 2.0 mmol) were used and the product was purified by column
chromatography (silica gel/5% diethyl ether in hexanes) to afford 39 (0.095 g, 20%) as a
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colorless liquid: IR (neat) 2957, 1458, 1378, 1190, 1113, 734, 672 cm-1; 1 H  6.33 (1 H, d, J =
9.9 Hz), 6.00 (2 H, m), 5.73 (1 H, dt, J = 9.6 and 3.3 Hz), 3.58 (1 H, dt, J = 9.6 and 4.5 Hz), 3.40
(1 H, t, J = 9.3 Hz), 3.32 (3 H, s), 3.13 (1 H, dd, J = 8.9 and 5.2 Hz), 2.21 (2 H, m), 2.08 (1 H,
m), 1.95 (1 H, m), 1.45 - 1.25 (8 H, m), 0.92 (3 H, t), 0.91 (3 H, t); 13C  143.06, 130.74, 127.38,
124.74, 123.40, 121.17, 78.05, 58.94, 38.30, 31.76, 31.36, 31.03, 23.18, 22.97, 14.10, 14.05; MS
(m/z) 248 (M+), 216, 203, 185, 147, 133, 117, 91, 77, 45.
6-(Cyclohexylmethyl)-5-dibutylmethylene-1,3-cyclohexadiene (40).  The same procedure was
repeated as described for 34 except that 3-cyclohexyl-1-propyne (0.244 g, 2.0 mmol), and 5-
butyl-3,4-nonadien-1-yne (0.352 g, 2.0 mmol) were used to obtain 40 (0.175 g, 30%) as a light
yellow liquid. IR (neat) 2923, 1448, 1377, 989,786, 762, 734 cm-1; 1H  6.33 (1 H, d, J = 9.7 Hz),
5.94 (2 H, m), 5.73 (1 H, m), 3.29 (1 H, td, J = 5.7 and 4.6 Hz), 2.19-0.9 (31 H, m); 13C  140.67,
132.98, 132.32, 124.52, 122.45, 121.01, 46.06, 35.06, 34.41, 34.18, 32.40, 31.85, 31.66, 31.57,
31.01, 26.77, 26.51, 26.42, 23.30, 23.05; MS (m/z) 300 (M+), 241, 203, 185, 147, 133, 91, 55.
9-Butyl-2,2-dimethyl-3,5,7,8-tridecatetraene (41a).  The same procedure was repeated as
described for 34 except that 3,3-dimethyl-1-butyne (0.25 mL, 2.0 mmol) and 5-butyl-3,4-
nonadien-1-yne (0.352 g, 2.0 mmol) were used to obtain 41a (0.213 g, 41%) as a colorless liquid:
IR (neat) 2957, 1950, 1465, 1366, 978 cm-1;  1H  6.38 (1 H, dd, J = 15.3 and 11.0 Hz), 6.22 (1
H, dd of quintet, J = 11.1, 2.8, and 1 Hz), 5.87 (1 H, t, J = 10.8 Hz), 5,73 (1 H, d, J = 15.2 Hz),
5.68 (1 H, t, J = 10.9 Hz), 1.97 (4 H, dt, J = 2.8 and 8.1 Hz), 1.45 - 1.25 (8 H, m), 1.05 (9 H, s),
0.89 (3 H, t); 13C  205.42, 146.47, 127.95, 124.79, 120.20, 105.50, 90.93, 33.46, 32.39, 29.81,
29.56, 22.40, 13.99.
2-Heptyn-1-ol (44).  To a 500 mL flask were introduced 150 mL of dry THF, 24.65 g (300
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mmol) of 1-hexyne under N2, and the mixture was cooled to -20 C. A solution of 120 mL of
 n-BuLi (2.5 M in hexanes, 300 mmol) was added and the reaction temperature was kept at 0 C. 
The resulting yellow solution was stirred for another 15 min.  A suspension of 18 g of
paraformaldehyde in 100 mL of THF was introduced rapidly and the cooling bath was  removed.
After 2 h of stirring, the reaction mixture was quenched with a saturated ammonium chloride
solution and the mixture was stirred for 10 min.  The mixture was then extracted with pentane (3
x 20 mL).  The combined pentane layers were washed with a sodium chloride solution and dried
over magnesium sulfate.  Solvent was removed and the residue was distilled (bp 81 C/6.0
mmHg) under reduced pressure to afford 44 (30.24 g, 90%) as a colorless liquid: IR (neat) 3346,
2931, 2225, 1466, 1137, 1012 cm-1; 1H  4.20 (2 H, s), 2.19 (2 H, tt, J = 6.9 and 1.9 Hz), 1.42 (4
H, m), 0.86 (3 H, t, J = 6.9 Hz); 13C  85.74, 78.39, 50.63, 30.65, 21.86, 18.32, 13.43; MS (m/z)
112 (M+), 97, 93, 83, 79, 70, 65, 55, 52.
3-Butyl-1,2-heptadiene (45).  To a 500-mL flask were charged with 44 (22.4 g, 200 mmol) and
200 mL of THF.  A 2.5 M solution of n-BuLi (80 mL, 200 mmol) was added below 10 C and
the solution was stirred at 0 C for another 30 min before cooling  to -78 C with a dry ice-
acetone bath.  A solution of p-toluenesulfonyl chloride (38.13 g, 200 mmol) in 100 mL of THF
was added.  After 30 min at -50 C the cooling bath was removed and the pale yellow reaction
mixture was allowed to warm to room temperature, and it was stirred for 2 h.  To a  1 L-flask 
equipped with a mechanical stirrer was introduced anhydrous lithium bromide (19.63 g, 226
mmol) and anhydrous cuprous bromide (32.42 g, 226 mmol), which were dried under 0.06 Torr
at 120 C for 5 h before use.  The reaction flask was evacuated and the contents were briefly
heated.  After 30 min, dry nitrogen was introduced to restore pressure.  Then 150 mL of THF was
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added at room temperature with vigorous stirring, and the mixture was cooled to -40 C.  A 2.0
M solution of n-butylmagnesium chloride in THF (100 mL, 200 mmol) was added rapidly via
cannula.  After 30 min of vigorous stirring for at -40 C, the reaction mixture was cooled to -70
C.  The reaction mixture in the 500-mL flask was transferred via cannula over 45 min to the
cuperate mixture kept at -70 C with a dry ice-acetone bath.  After 30 min, the bath was removed
and the reaction mixture was stirred at room temperature for 2 h.  The mixture was  then poured
into a saturated NH4Cl solution (200 mL), pentane (100 mL) was added and the mixture was
filtered. The organic layer was separated, and the aqueous layer was extracted with pentane (3 x
50 mL).  The combined organic layers were washed with water (10 x 50 mL), dried over MgSO4,
and concentrated.  The residue was distilled (bp 79 C/4.0-6.0 mmHg) under reduced pressure to
afford 45 (25.22 g, 83 %) as a colorless liquid: IR (neat) 2959, 2872, 1962, 1466, 1363, 1177,
1070, 912, 692 cm-1; 1H  4.62 (2 H, quintet, J = 3.2 Hz), 1.93 (4 H, m), 1.38 (8 H, m), 0.90 (6 H,
t, J = 6.9 Hz); 13C  205.78, 103.29, 75.15, 31.91, 29.82, 22.51, 13.99; MS (m/z) 152 (M+), 137,
123, 110, 107, 95, 81, 68, 55, 41.
1-Iodo-2-(trimethylsilyl)acetylene (46).  To a 500-mL flask containing trimethylsilylacetylene
(15.72 g, 160 mmol) and 160 mL of THF solution was introduced n-BuLi (64 mL, 2.5 M, 160
mmol) by cannula at -30 C.  After 30 min, a solution of I2 (42.64 g, 168 mmol) in 100 mL THF
was introduced.  During the early stage of the addition, the I2 brown color disappeared quickly
until the reaction almost reach the end point and a brown solution was formed.  The solution was
then poured to a flask containing 160 mL H2O at 0 C and stirred for 10 min.  Then a solution of
sodium thiosulfate was added to remove the unreacted I2.  After separation of the two layers, the
aqueous layer was extracted with pentane (3 x 40 mL) and the combined organic layers were
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washed with water (10 x 50 mL) to remove THF solvent.  The organic layer was then dried over
magnesium sulfate and concentrated.  The crude product was distilled (bp 45 C, 6.0 mmHg) to
afford 46 (29.77 g, 83%) as a colorless liquid: IR (neat) 2959, 2899, 2100, 1409, 1251, 869, 746,
701 cm-1; 1H  0.17 (9 H, s ); 13C  104.10, 20.77, -0.087; MS (m/z) 224 (M+), 209, 179, 170,
155, 127, 104, 97, 67, 53.
1-(Trimethylsilyl)-5-butyl-3,4-nonadien-1-yne (47).  To 3-butyl-1,2-heptadiene 4515 (7.362 g,
48.2 mmol) in 150 mL of THF at -60 C under an N2 atmosphere was added 19.3 mL of a 2.5 M
solution of n-butyllithium in hexanes.  After 1 h at -60 C, 7.61 g (53.0 mmol) of anhydrous
CuBr in 60 mL of THF was introduced via cannula, and the mixture was allowed to warm to 
-20 C.  The mixture was then cooled to -40 C and 11.88 g (53 mmol) of 1-iodo-2-
(trimethylsilyl)acetylene15 was added dropwise over 1 h.  After an additional 1 h at -40 C, the
mixture was allowed to warm to 0 C and then was poured into a saturated NH4Cl solution.
Pentane (30 mL) was added and the mixture was filtered.  The organic layer was separated, and
the aqueous layer was extracted with pentane (3 x 40 mL). The combined organic layers were
washed with water, dried over MgSO4, and concentrated.  The residue was distilled (bp 75 C,
0.2 Torr) to afford 1-(trimethylsilyl)-5-butyl-3,4-nonadien-1-yne (47) (8.658 g, 73%)  as a
colorless liquid10a: 1H  5.32 (1 H, quintet, J = 2.9 Hz), 1.98 (4 H, m), 1.38 (8 H, m), 0.88 (6 H, t,
J = 7.1 Hz), 0.15 (9 H, s); 13C  210.33, 106.76, 99.59, 93.33, 76.26, 32.02, 29.52, 22.35, 13.94,
0.05; MS (m/z) 233 (M+-CH3), 219, 191, 177, 164, 149, 131, 107, 97, 73, 59.
5-Butyl-3,4-nonadien-1-yne (48).  The conjugated allenyne 48 was synthesized according to the
reported procedures.10  To 3.754 g (15.14 mmol) of 1-(trimethylsilyl)-5-butyl-3,4-nonadien-1-yne 
in 140 mL of ethanol under a nitrogen atmosphere was added 36.0 mL of a 0.1 N aqueous NaOH
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solution.  After 24 h at rt, the mixture was poured into ice/water and was extracted with pentane. 
The organic layer was washed with a saturated NH4Cl solution, dried over MgSO4, and
concentrated.  The residue was distilled (bp 38 C, 0.09 Torr) to furnish 2.383 g (90%) of 48 as a
colorless liquid: IR (neat) 3314, 2105, 1955, 1466, 1379 cm-1; 1H  5.30 (1 H, sextet, J = 2.8 Hz),
2.75 (1 H, d, J = 2.4 Hz), 1.99 (4 H, m), 1.37 (8 H, m), 0.90 (6 H, t); 13C  210.47, 107.34, 78.32,
76.20, 74.98, 31.89, 29.44, 22.32, 13.85; MS m/z 161 (M+-CH3), 147, 134, 119, 105, 91, 77. 
Allenyldicyclohexylborane (74).  The procedure for the synthesis of B-allenyl-9-
borabicyclo[3.3.1]nonane39 was adopted for the preparation of 74.  Allenylmagnesium bromide
was prepared as described previously.35  To 0.48 g (20.0 mmol) of magnesium turnings under a
nitrogen atmosphere were added 20 mL of anhydrous diethyl ether and 2 drops of 1,2-
dibromoethane.  After 10 min, 0.010 g of mercury(II) chloride was added followed by dropwise
addition of 1.34 mL of a 80% (weight) solution of propargyl bromide (12.0 mmol) in toluene
over 20 min.  The reaction flask was immersed in a cold water bath when the Grignard reaction
became too vigorous.  The reaction mixture was stirred at rt for 1 h.  The resulting mixture was
then transferred via cannula to a flask containing 10.0 mL of a 1.0 M solution of
chlorodicyclohexylborane (10.0 mmol) in hexanes and 20 mL of diethyl ether maintained at 78
C.  After 30 min, the mixture was allowed to warm to rt.  After 1 h, stirring was discontinued to
allow magnesium salt to settle.  The solution was transferred via cannula to centrifuge tubes for
centrifugation.  The clear supernatant liquid was transferred via cannula to a flask and was
concentrated in vacuo.  The residue was distilled in vacuo (bp 98C, 0.02 Torr) to give 1.372 g
(6.35 mmol, 64%) of 74 as a colorless liquid: 1H  5.56 (1 H, t, J = 6.5 Hz), 4.56 (2 H, d, J = 6.7
Hz), 1.76–1.62 (6 H, m), 1.53–1.43 (4 H, m), 1.28–1.14 (12 H, m); 13C  220.15,  87.5 (br),
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68.54, 34.5 (br), 27.49, 27.43, 27.01.
4-(1-Cyclohexenyl)-3-methylphenol (80).  The following procedure for the preparation of 80 is
representative.  To 0.264 g (2.00 mmol) of 5,5-(pentamethylene)-3,4-pentadien-1-yne in 20 mL
of THF at 78 C was added 1.25 mL (2.00 mmol) of a 1.6 M solution of n-butyllithium in
hexanes.  After 30 min at 78 C, 0.475 g (2.20 mmol) of 74 in 10.0 mL of THF was introduced
via cannula.  After 30 min, the mixture was allowed to warm to rt.  After an additional 2 h, the
mixture was cooled to 0 C, and 2.0 mL of a 1.0 M solution of trimethyltin chloride (2.0 mmol)
in THF was added with a syringe.  After 15 h stirring at rt, the mixture was transferred via
cannula to a flask containing a mixture of 2.0 mL of a 30% H2O2 solution and 2 mL a 6 N NaOH
solution in 15 mL of methanol at 0 C.  The reaction mixture was heated at 50 C for 1 h before
it was allowed to cool to rt.  Glacial acetic acid (2.0 mL) was added, and the mixture was heated
at 50 C for 2 h.  The organic layer was separated, and the aqueous layer was extracted with
pentane (3 × 20 mL). The combined organic layers were washed with water, dried over MgSO4,
and concentrated.  The residue was purified by column chromatography (silica gel/20% Et2O in
hexanes) to furnish 0.192 g (1.02 mmol, 51%) of 80 as a light yellow liquid: IR (neat) 3331,
1605, 1581, 1226, 857, 812 cm1; 1H  6.96 (1 H, d, J = 8.1 Hz), 6.68 (1 H, d, J = 2.6 Hz), 6.65
(1 H, dd, J = 8.1 and 2.6 Hz), 5.60 (1 H, s), 5.54 (1 H, tt, J = 3.6 and 1.8 Hz), 2.25 (3 H, s),
2.21–2.14 (4 H, m), 1.82–1.65 (4 H, m); 13C  153.60, 138.17, 137.47, 136.66, 129.37, 125.76,
116.61, 112.23, 30.32, 25.38, 23.09, 22.15, 19.84; MS (m/z) 188 (M+), 173, 160, 159, 145. 
1-(1-Cyclohexenyl)-5-iodo-2-methyl-4-(2-propenyl)benzene (81).  The same procedure was
repeated as described for 80 except that after 15 h of stirring following the introduction of
trimethyltin chloride, the mixture was cooled to 78 C.  A solution of a 1.6 M n-butyllithium in
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hexanes (1.25 mL, 2.0 mmol) was added with a syringe.  After 15 min, the reaction mixture was
transferred via cannula to a flask containing 0.452 g (2.20 mmol) of CuBrSMe2 and 15 mL of
THF maintained at 78 C.  After 1 h at 78 C, 0.726 g (6.00 mmol) of allyl bromide was
introduced dropwise, and the reaction mixture was stirred at 78 C for 1 h before it was allowed
to warm to rt.  A solution of 1.02 g of iodine (4.00 mmol) in 10 mL of diethyl ether was added
via cannula.  The resulting mixture was stirred at rt for 1 h followed by the addition of a saturated
Na2S2O3 solution to destroy excess I2.  An additional 30 mL of water and 40 mL of Et2O were
added, and the organic layer was then separated, washed with a saturated NaCl solution, dried
over MgSO4, and concentrated.  The residue was purified by column chromatography (silica
gel/hexanes) to afford 0.203 g (0.60 mmol, 30%) of 81 as a yellow oil: IR (neat) 991, 914 cm1;
1H  7.54 (1 H, s), 7.00 (1 H, s), 5.96 (1 H, ddt, J = 16.6, 10.3, and 6.6 Hz), 5.55 (1 H, tt, J = 5.5
and 2.8 Hz), 5.14 (1 H, dq, J = 10 and 1.6 Hz), 5.12 (1 H, dq, J = 17 and 1.8 Hz), 3.44 (2 H, dt, J
= 6.5 and 1.5 Hz), 2.20 (3 H, s), 2.19–2.11 (4 H, m), 1.79–1.62 (4 H, m); 13C  144.70, 140.34,
138.73, 137.31, 136.01, 135.51, 131.04, 126.48, 116.44, 96.75, 44.42, 29.89, 25.33, 22.96, 22.06,
19.36; MS (m/z) 338 (M+), 297, 211, 170, 169. Anal. Calcd for C16H19I: C, 56.82; H, 5.66.
Found: C, 57.04; H, 5.68.
4-(1-Butyl-1-pentenyl)-3-methylphenol (83).  The same procedure was repeated as described
for 80 except that 0.352 g (2.00 mmol) of 5-butyl-3,4-nonadien-1-yne (48) was treated with 0.80
mL (2.00 mmol) of a 2.5 M solution of n-butyllithium in hexanes to produce 30 followed by
0.561 g (2.6 mmol) of 74.  The phenol 83 (0.279 g, 1.20 mmol, 60%) was isolated as a light
yellow liquid: IR (neat) 3353, 1607, 1581, 1235, 860, 816 cm1; 1H  6.89 (1 H, d, J = 8.1 Hz),
6.63 (1 H, dd, J = 2.6 Hz), 6.58 (1 H, dd, J = 8.1 and 2.6 Hz), 5.18 (1 H, t, J = 7.3 Hz), 4.65 (1 H,
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br s, OH), 2.28 (2 H, t, J = 7.4 Hz), 2.20 (3 H, s), 2.12 (2 H, q, J = 7.3 Hz), 1.43 (2 H, sextet, J =
7.3 Hz), 1.34–1.20 (4 H, m), 0.94 (3 H, t, J = 7.3 Hz), 0.87 (3 H, t, J = 6.8 Hz); 13C  153.68,
140.09, 137.39, 136.93, 130.09, 129.69, 116.48, 111.91, 31.71, 30.36, 30.11, 23.02, 22.83, 20.04,
14.01, 13.90; MS (m/z) 232 (M+), 217, 203, 190, 175, 161, 148, 147.  A minor set of the 1H NMR
signals attributable to the presence of the other geometric isomer (isomer ratio = 84:16) at 
(partial) 6.80 (1 H, d, J = 8.1 Hz), 6.66 (1 H, d, J = 2.6 Hz), and 5.42 (1 H, tt, J = 7.3 and 1.1 Hz)
was also observed.
trans-(±)-4b,5,6,7,8,8a,9,10-Octahydro-2-phenanthrenol (87).  The same procedure was
repeated as described for 80 except that 0.292 g (2.00 mmol) of 3,4,10-undecatrien-1-yne (96)
was used to prepare 84.  To facilitate purification of 87, the products isolated after column
chromatography were treated with an excess of a 2.0 M solution of BH3SMe2 in THF followed
by oxidation with an alkaline 30% H2O2 solution.  This treatment allowed conversion of
undesired side products containing a terminal carbon–carbon double bond to more polar adducts
having a hydroxyl group.  Further purification by column chromatography afforded 0.023 g (0.11
mmol, 6 %) of 8740 as a white solid: IR 3302, 1610, 1247, 802 cm1; 1H  7.14 (1 H, d, J = 8.3
Hz), 6.61 (1 H, dd, J = 8.4 and 2.9 Hz), 6.54 (1 H, d, J = 2.8 Hz), 4.51(1 H, br s, OH), 2.84 (1 H,
ddd, J = 17.0, 11.5, and 5.9 Hz), 2.73 (1 H, ddd, J = 16.8, 6.0, and 2.4 Hz), 2.39 (1 H, dm, J =
12.9 and 3.4 Hz), 2.18 (1 H, td, J = 10.7 and 2 Hz), 1.93–1.84 (1 H, m), 1.8–1.7 (3 H, m),
1.5–1.1 (6 H, m); 13C  153.09, 138.68, 133.10, 126.61, 115.16, 112.62, 43.24, 40.80, 34.24,
31.19, 30.64, 30.01, 26.89, 26.31; MS (m/z) 202 (M+), 174, 159, 145.  The assignment of the
trans geometry to 87 is based on the coupling constant of ca. 10.7 Hz for the two anti hydrogen
atoms with the benzylic methine hydrogen at 2.18 ppm.  The 1H NMR chemical shift of the
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benzylic methine hydrogen and the 13C NMR chemical shifts of the aliphatic carbons are also
consistent with the assignment of the trans geometry to 34 when compared with those of trans-
1,2,3,4,4a,9,10,10a-octahydrophenanthrene reported previously.3a  A minor set of the 1H NMR
signals (partial) attributable to 4-[(1E)-1,6-heptadienyl]-3-methylphenol (ca. 1%) at  7.28 (1 H,
d, J = 9 Hz), 6.48 (1 H, dt, J = 15.8 and 1.5 Hz), 5.94 (1 H, dt, J = 15.6 and 6.9 Hz) was also
observed.
4-(1-Butyl-1-pentenyl)-3-pentylphenol (94).  The following procedure for the preparation of 94
is representative.  To 0.352 g (2.00 mmol) of 5-butyl-3,4-nonadien-1-yne (48) in 20 mL of THF
at 78 C under a nitrogen atmosphere was added 0.80 mL (2.0 mmol) of a 2.5 M solution of n-
butyllithium in hexanes.  After 30 min at 78 C, 0.416 g (2.00 mmol) of B-
methoxydicyclohexylborane in 10.0 mL THF was introduced via cannula.  After 1.5 h of stirring
at 78 C, 0.33 mL (2.67 mmol) of BF3OEt2 was added with a syringe, and the mixture was
allowed to warm to rt.  Solvent was removed in vacuo, and the remaining yellow viscous residue
was dissolved in 30 mL of pentane.  The solution was transferred to centrifuge tubes via cannula
for centrifugation.  The supernatant liquid was then transferred via cannula to a flask.  Pentane
was removed in vacuo to furnish 88 as a colorless viscous liquid.  Anhydrous THF (35 mL) was
added, and the solution was cooled to 78 C.  To a second flask containing 0.202 g (2.1 mmol)
of 1,2-heptadiene in 15 mL of THF 78 C was added 0.80 mL (2.0 mmol) of a 2.5 M solution
of n-butyllithium in hexanes.  After 30 min of stirring at 78 C, 1-lithio-1,2-heptadiene (89)
was added via cannula to the flask containing 88.  After 1 h of stirring at 78 C, the mixture
was allowed to warm to rt and stirred for an additional 3 h.  The mixture was then cooled to 0C,
and 2.0 mL of a 1.0 M solution of trimethyltin chloride in THF was introduced with a syringe. 
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After 14 h of stirring at rt, the mixture was transferred via cannula to a flask containing 2 mL of
30% H2O2, 2.0 mL of a 6 N NaOH solution, and 15 mL of methanol at 0 C.  The reaction
mixture was heated at 50 C for 1 h.  Glacial acetic acid (2 mL) was added, and the mixture was
heated at 50C for an additional 2 h before it was allowed to cool to rt.  The organic layer was
separated, and the aqueous layer was extracted with pentane (3 × 20 mL).  The combined organic
layers were washed with water, dried over MgSO4, and concentrated.  The residue was purified
by column chromatography (silica gel/20% Et2O in hexanes) to furnish 0.351 g (1.22 mmol,
61%) of 94 as a light yellow liquid: IR (neat) 3341, 1606, 1581, 1230, 817 cm1; 1H  6.91 (1 H,
d, J = 8.3 Hz), 6.70 (1 H, d, J = 2.6 Hz), 6.61 (1 H, dd, J = 8.1 and 2.8 Hz), 5.21 (1 H, t, J = 7.3
Hz), 5.17 (1 H, br s, OH), 2.52 (2 H, t, J = 8.0 Hz), 2.29 (2 H, t, J = 7.3 Hz), 2.15 (2 H, q, J = 7.3
Hz), 1.6–1.5 (2 H, m), 1.45 (2 H, sextet, J = 7.3 Hz), 1.37–1.23 (8 H, m), 0.97 (3 H, t, J = 7.3
Hz), 0.90 (3 H, t, J = 6.7 Hz), 0.87 (3 H, t, J = 6.9 Hz); 13C  153.73, 141.96, 140.03, 137.12,
130.41, 129.80, 115.30, 111.93, 32.94, 32.27, 31.98, 31.28, 30.41, 30.14, 23.03, 22.86, 22.54,
14.02, 13.99, 13.90; MS (m/z) 288 (M+), 259, 231, 217, 189, 175, 161; HRMS calcd for C20H32O
288.2453, found 288.2442.  Anal. Calcd for C20H32O: C, 83.27; H, 11.18. Found: C, 83.15; H,
11.19.  A minor set of the 1H NMR signals (partial) at  6.81 (1 H, d, J = 8.3 Hz), 6.74 (1 H, d, J
= 2.6 Hz), 6.64 (1 H, dd, J = 8 and 2.6 Hz), and 5.45 (1 H, tt, J = 7.1 and 1.2 Hz) attributable to
the presence of the other geometric isomer (isomer ratio = 87:13) was also observed. 
1-(1-Butyl-1-pentenyl)-2-pentylbenzene (95).  The same procedure was repeated as described
for 94 except that the reaction mixture was treated with acetic acid directly.  Purification by
column chromatography (silica gel/hexanes) furnish 0.310 g (1.14 mmol, 57%) of 95 as a yellow
oil: IR (neat) 1457, 758 cm1; 1H  7.24–7.20 (2 H, m), 7.19–7.11 (1 H, m), 7.07 (1 H, dm, J =
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6.9 and 1.3 Hz), 5.28 (1 H, t, J = 7.3 Hz), 2.61 (2 H, t, J = 8.0 Hz), 2.38 (2 H, t, J = 7.3 Hz), 2.21
(2 H, q, J = 7.3 Hz), 1.63 (2 H, m), 1.50 (2 H, sextet, J = 7.3 Hz), 1.42–1.28 (8 H, m), 1.02 (3 H,
t, J = 7.3 Hz), 0.94 (3 H, t, J = 6.7 Hz), 0.91 (3 H, t, J = 6.7 Hz); 13C  144.31, 140.63, 140.20,
129.60, 129.34, 128.75, 126.30, 124.97, 32.98, 32.19, 32.10, 31.55, 30.49, 30.14, 23.06, 22.91,
22.59, 14.05, 13.99, 13.92; MS (m/z) 272 (M+), 215, 201, 173, 159, 145, 117; HRMS Calcd for
C20H32 272.2504, found 272.2481.  A minor 1H NMR signal of the alkenyl hydrogen of the other
geometric isomer at  5.50 (tt, J = 7.1 and 1 Hz) was also observed.  
(±)-10-Butyl-4b,5,6,7,8,8a,9,10-octahydro-2-phenanthrenol (105), 4-[(1E)-1,6-
Heptadienyl]-3-pentylphenol (106), and 4-(6-Heptenyl)-3-[(E)-1-pentenyl]phenol (107).  The
same procedure was repeated as described for 94 except that 0.292 g (2.0 mmol) of 96 was used. 
Purification by column chromatography (silica gel/10% diethyl ether in hexanes) furnished 0.232
g (0.90 mmol, 45%) of a mixture of 105 (20%), 106 (10%) and 107 (15%) as a colorless liquid. 
The amounts of 105, 106, and 107 in the mixture were determined by integration of the 1H NMR
spectrum.  It was possible to separate 105 and 107 from the mixture by HPLC.  A fraction
containing predominantly 106 was also obtained.  105: IR (neat) 3342, 1609, 1582, 1244, 733
cm1; 1H  7.13 (1 H, d, J = 8.8 Hz), 6.63 (1 H, d, J = 8 Hz), 6.60 (1 H, s), 4.77 (1 H, br s, OH),
2.66 (1 H, m), 2.39 (1 H, dm, J = 12 and 3 Hz), 2.12 (1 H, tm, J = 11 and 3 Hz), 1.94–1.1 (16 H,
m), 0.92 (3 H, t, J = 7.1 Hz); 13C  153.13, 143.85, 132.76, 126.21, 115.38, 112.71, 43.74, 38.21,
37.84, 35.61, 34.34, 33.92, 30.96, 30.38, 26.92, 26.43, 22.84, 14.13; MS (m/z) 258 (M+), 201,
174, 159, 145, 133.  106: 1H (partial)  7.29 (1 H, d, J = 8.2 Hz), 6.60 (2 H, m), 6.51 (1 H, dt, J =
15.4 and 1.6 Hz), 5.94 (1 H, dt, J = 15.4 and 6.9 Hz); 13C  154.36, 141.50, 138.76, 130.22,
129.43, 127.11 (2 carbons), 115.86, 114.55, 112.97, 33.32, 33.20, 32.65, 31.72, 30.46, 28.73,
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22.53, 14.03.  107: IR (neat) 3354, 1640, 1607, 1578, 1245, 993, 964, 909, 867, 821 cm1; 1H 
6.96 (1 H, d, J = 8.2 Hz), 6.90 (1 H, d, J = 2.6 Hz), 6.62 (1 H, dd, J = 8.3 and 2.7 Hz), 6.54 (1 H,
dt, J = 15.7 and 1.1 Hz), 6.05 (1 H, tt, J = 15.6 and 6.9 Hz), 5.80 (1 H, ddt, J = 17.0, 10.2, and
6.6 Hz), 4.98 (1 H, dm, J = 17 and 2 Hz), 4.93 (1 H, dm, J = 10 and 1 Hz), 4.73 (1 H, br s, OH),
2.56 (2 H, t, J = 7.7 Hz), 2.19 (2 H, qd, J = 7.3 and 1.7 Hz), 2.04 (2 H, qm, J = 6.6 and 1 Hz),
1.6–1.3 (8 H, m), 0.95 (3 H, t, J = 7.3 Hz); 13C  153.57, 139.08, 137.74, 132.58, 132.22, 130.51,
127.27, 114.20, 113.77, 112.24, 35.31, 33.71, 32.49, 31.06, 28.94, 28.75, 22.55, 13.68; MS (m/z)
258 (M+), 229, 215, 201, 187, 175, 145, 133.  The assignment of the trans ring junction to 105 is
based on the 1H NMR chemical shift of the benzylic methine hydrogen at 2.12 ppm as observed
in the case of 87.  The structures of 106 and 107 were assigned on the basis of the 1H NMR
chemical shifts of the aromatic hydrogens at the meta position.  The chemical shift of the meta
aromatic hydrogen of 106 at 7.29 ppm is essentially identical to that of 4-[(1E)-1,6-heptadienyl]-
3-methylphenol at 7.28 ppm.
2-(1-Decynyl)-N-(triphenylphosphoranylidene)benzenamine (109g).46  To 3.68 g (8.72 mmol)
of Ph3PBr2 were added 1.815 g (7.93 mmol) of 2-(1-decynyl)aniline (108g), 2.1 mL of anhydrous
triethylamine, and 60 mL of anhydrous benzene under a nitrogen atmosphere.  The reaction
mixture was heated under reflux for 5 h.  The white triethylammonium bromide precipitate was
removed by filtration, and the filtrate was concentrated.  Purification by column chromatography
(silica gel/20% diethyl ether in hexanes) afforded 2.876 g (5.88 mmol, 74%) of 109g as a yellow
liquid: IR (neat) 3053, 1584, 749, 716, 694 cm1; 1H  7.87–7.78 (6 H, m), 7.55–7.4 (9 H, m),
7.30 (1 H, dt, J = 7.7 and 2.0 Hz), 6.81 (1 H, td, J = 7.7 and 1.7 Hz), 6.58 (1 H, t, J = 7.3 Hz),
6.49 (1 H, d, J = 7.9 Hz), 2.49 (2 H, t, J = 7.3 Hz), 1.66 (2 H, quintet, J = 7.3 Hz), 1.45 (2 H,
77
quintet, J = 6.9 Hz), 1,24 (8 H, br), 0.86 (3 H, t, J = 6.7 Hz); 13C  152.26, 132.87, 132.68 (d, J =
9.8 Hz), 131.49 (d, J = 2.6 Hz), 131.36 (d, J = 99.9 Hz), 128.38 (d, J = 11.9 Hz), 127.58, 121.51
(d, J = 9.3 Hz), 119.44 (d, J = 21.7 Hz), 117.10, 92.41, 81.36, 31.81, 29.27, 29.24, 29.18, 22.61,
20.10, 14.07.
N-[2-(1-Pentynyl)phenyl]-N-phenylcarbodiimide (122d).  To 0.247 g of the
iminophosphorane 13420 (0.700 mmol) in 10 mL of anhydrous benzene was introduced via
cannula a solution of 0.13 g of 2-(1-pentynyl)phenyl isocyanate 133d (0.70 mmol) in 10 mL of
dry benzene under a nitrogen atmosphere at rt.  After 1 h, the reaction mixture was concentrated
in vacuo, and the residue was purified by flash column chromatography (silica gel/7% benzene in
hexanes) to afford 0.093 g (0.358 mmol, 51%) of 122d as a yellow oil: IR (neat) 2247, 2143,
2107, 1592, 756, 689 cm1; 1H  7.44 (1H, dd, J = 7.9 and 1.5 Hz), 7.4–7.08 (8 H, m), 2.10 (2 H,
t, J = 7.2 Hz), 1.46 (2 H, sextet, J = 7.3 Hz), 0.93 (3 H, t, J = 7.3 Hz); 13C  139.16, 138.72,
133.65, 133.01, 129.25, 128.39, 125.12, 125.05, 124.25, 124.19, 120.78, 98.70, 76.87, 21.69,
21.53, 13.40; MS m/z 260 (M+), 245, 231, 218; HRMS calcd for C18H16N2 260.1314, found
260.1312.
N-[2-(2-Phenylethynyl)phenyl]-N-phenylcarbodiimide (122f).  The same procedure was
repeated as described for 122d by using the method outlined in Scheme 3.  Treatment of 0.541 g
of 13420 (1.530 mmol) with 0.336 g 2-(2-phenylethynyl)phenyl isocyanate 133f (1.53 mmol) in
15 mL of anhydrous benzene afforded 0.353 g (1.20 mmol, 78%) of 122f as a pale yellow oil: IR
(neat) 2138, 1590, 754, 689 cm1; 1H  7.53 (1 H, dm, J = 7.7 and 1.5 Hz), 7.37–7.06 (13 H, m);
13C  138.75, 138.68, 133.25, 132.88, 131.54, 129.31, 129.27, 128.36, 128.05, 125.27, 125.19,
124.60, 124.31, 122.69, 119.99, 96.22, 85.56; MS m/z 294 (M+), 264, 216, 190, 176, 147, 77;
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HRMS calcd for C21H14N2 294.1157, found 294.1171. 
11-Propyl-6H-indolo[2,3-b]quinoline (127d).
  To 0.247 g of the iminophosphorane 13420
(0.700 mmol) in 10 mL of p-xylene was introduced via cannula a solution of 0.13 g of 2-(1-
pentynyl)phenyl isocyanate (133d, 0.70 mmol) in 10 mL of p-xylene under a nitrogen
atmosphere.  After 2 h at rt, the reaction mixture was heated under reflux for 12 h.  The reaction
mixture was then concentrated, and the residue was purified by flash chromatography (silica
gel/30% diethyl ether in hexanes) to afford 0.091 g (0.35 mmol, 50%) of 127d as yellow solid:
IR (KBr) 3455, 1611, 739 cm1; 1H  12.23 (1 H, br s, NH), 8.30 (1 H, d, J = 8.4 Hz), 8.22 (1 H,
d, J = 8.2 Hz), 8.17 (1 H, d, J = 7.9 Hz), 7.77 (1 H, d, J = 7.6 Hz), 7.6–7.48 (3 H, m), 7.31 (1 H,
t, J = 7.6 Hz), 3.65 (2 H, t,  J = 8.0 Hz), 1.98 (2 H, sextet, J = 7.6 Hz), 1.24 (3 H, t, J = 7.4 Hz);
13C  153.44, 146.26, 144.31, 141.38, 128.71, 127.45, 127.04, 124.17, 123.41, 122.67, 121.39,
119.99, 116.63, 110.93, 30.93, 22.92, 14.70; MS m/z 260 (M+), 231.
The indoloquinoline 127d (50% yield) was also synthesized in a one-pot operation from
134
 and phenyl isocyanate 133d without isolation of 122d.
11-Phenyl-6H-indolo[2,3-b]quinoline (127f).18
  To 0.225 g of the iminophosphorane 13420
(0.637 mmol) in 10 mL of anhydrous benzene was introduced via cannula a solution of 0.140 g
of 2-(2-phenylethynyl)phenyl isocyanate (133f, 0.639 mmol) in 10 mL of dry benzene under a
nitrogen atmosphere at rt.  After 1 h, the reaction mixture was heated under reflux for 5 h.  The
reaction mixture was then concentrated, and the residue was purified by flash chromatography
(silica gel/5% diethyl ether in hexanes) to afford 0.103 g (0.350 mmol, 55%) of 127f as pale
yellow solid: IR (KBr) 1593, 743 cm1; 1H  12.46 (1 H, br s, NH), 8.28 (1 H, d, J = 8.4 Hz),
7.81–7.73 (3 H, m), 7.7–7.65 (3 H, m), 7.57–7.52 (3 H, m), 7.44–7.37 (2 H, m), 7.08 (1 H, d, J =
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7.4 Hz), 6.98 (1 H, td, J = 7.5 and 1.1 Hz); 13C  153.36, 146.18, 142.80, 141.55, 136.37, 129.35,
128.95, 128.55, 127.87, 126.59, 126.40, 123.69, 123.06, 122.85, 121.04, 119.70, 116.75, 110.79;
MS m/z 294 (M+), 293, 264, 146. Anal. Calcd for C21H14N2: C, 85.69; H, 4.79; N, 9.52. Found: C,
85.74; H, 4.84; N, 9.50.
The indoloquinoline 127f (55% yield) was also synthesized in a one-pot operation from
134
 and 2-(2-phenylethynyl)phenyl isocyanate 133f without isolation of 122f.
Methyl 2-(1-Propynyl)benzoate (131c).  The following procedure for the preparation of 131c is
representative. To a degassed solution containing 1.53 g of Pd(PPh3)2Cl2   (2.18 mmol), 0.414 g of
CuI (2.18 mmol), 6.685 g of methyl 2-iodobenzoate (130, 25.0 mmol), and 13.75 mL of N,N-
diisopropylethylamine (79.0 mmol) in 80.0 mL of DMF was treated with 1000 mL of gaseous
propyne intraduced with a gaslight syringe (45.0 mmol).  After 24 h at rt, the reaction mixture
was poured into a flask containing 100 mL of a saturated NH4Cl solution and 100 mL of pentane. 
After filtration, the organic layer was separated, washed with water, dried over MgSO4, and
concentrated.  The residue was purified by flash chromatography (silica gel/5% diethyl ether in
hexanes) to afford 131c (4.26 g, 24.5 mmol, 98%) as a light yellow liquid: IR (neat) 1731, 1250,
757, 502 cm-1; 1H  7.89 (1 H, dd, J = 7.9 and 1.4 Hz), 7.52 (1 H, dd, J = 7.7 and 1.3 Hz), 7.42 (1
H, td, J = 7.6 and 1.4 Hz), 7.31 (1 H, td, J = 7.3  and 1.4 Hz), 3.92 (3 H, s), 2.13 (3 H, s); 13C 
166.85, 134.26, 131.75, 131.55, 130.12,  127.14, 124.57, 91.47, 78.30, 52.12, 4.77; MS m/z 174
(M+), 159, 143, 115, 77, 51; HRMS calcd for C11H10O2 174.0681, found 174.0686.
Methyl 2-(1-Pentynyl)benzoate (131d).
  To a degassed solution containing 1.755 g of
Pd(PPh3)2Cl2  (2.50 mmol), 0.488 g of CuI (2.56 mmol), 6.55 g of methyl 2-iodobenzoate (130,
25.0 mmol), and 14.0 mL of N,N-diisopropylethylamine (80.4 mmol) in 80 mL of DMF was
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added via cannula a degassed solution of 3.4 g (4.9 mL) of 1-pentyne (50 mmol) in 25 mL DMF. 
After 24 h at rt, the reaction mixture was poured into a flask containing 200 mL of a saturated
NH4Cl solution and 200 mL of pentane.  After filtration, the organic layer was separated, washed
with water, dried over MgSO4, and concentrated.  The residue was distilled in vacuo to afford
5.00 g (24.8 mmol, 99%) of 131d as a light yellow oil: IR (neat) 2234, 1731, 757, 702 cm1;  1H 
7.84 (1 H, dd, 
 J = 7.9 and 1.5 Hz), 7.47 (1 H, dd, J = 7.8 and 1.4 Hz),  7.36 (1 H, td,  J = 7.7 and
1.5 Hz), 7.25 (1 H, td, 
 J = 7.4 and 1.5 Hz), 3.86 (3 H, s), 2.41 (2 H, t, J = 7.1 Hz), 1.62 (2 H,
sextet, J = 7.2 Hz), 1.03 (3 H, t,  J = 7.4 Hz); 13C  166.74, 133.99, 131.74, 131.26, 129.92,
126.92, 124.28, 95.61, 79.21, 51.80, 21.97, 21.57, 13.36; MS m/z 202 (M+), 174, 159, 143.
Methyl 2-[2-(1-Cyclohexenyl)ethynyl]benzoate (131e).   The same procedure was repeated as
described for 131c except that 1.053 g of Pd (PPh3)2Cl2 (1.50 mmol), 0.285 g of CuI (1.50
mmol), 3.931 g of methyl 2- iodobenzoate 130 (15.0 mmol), and 7.84 mL of N,N-
diisopropylethylamine (45.0 mmol) in 30.0 mL of DMF was added via cannula a degassed
solution of 2.46 g of 1-ethynylcyclohexene  (22.94 mmol) in 10.0 mL of DMF to afford 131e
(3.27 g, 13.63 mmol, 91%) as a light yellow liquid: IR (neat) 2201, 1731, 1594, 756, 700 cm-1;
1H  7.91 (1 H, dd, J = 7.8 and 1.4 Hz), 7.52 (1 H, dd, J = 7.7 and 1.5 Hz), 7.42 (1 H, td, J = 7.5
and 1.5 Hz), 7.30 (1 H, td, J = 7.5 and 1.5 Hz), 6.27 (1 H, m), 2.26 (2 H, m), 2.14 (2 H, m), 1.66
(4 H, m); 13C  166.85, 135.98, 133.81, 133.81, 131.53, 130.33, 127.30, 124.19, 120.92, 96.38,
85.67, 52.05, 29.03, 25.83, 22.29, 21.49; MS m/z 240 (M+), 225, 210, 197, 179, 165, 79; HRMS
calcd for C16H16O2 240.1150, found 240.1148.
Methyl 2-(Phenylethynyl)benzoate (131f).
  The same procedure was repeated as described for
131d
 except that a solution of 4.692 g of phenylacetylene (46.00 mmol) in 20 mL of DMF was
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introduced via cannula to a degassed solution containing 1.734 g of Pd(PPh3)4  (1.50 mmol), 0.58
g of CuI (3.0 mol), 8.022 g of 130 (30.61 mmol), and 11.64 g of N,N-diisopropylethylamine
(90.06 mmol) in 40 mL of DMF.  Purification by flash chromatography (silica gel/5% diethyl
ether in hexanes) afforded 6.36 g of 131f (27.0 mmol, 88%) as a yellow liquid: IR (neat) 2217,
1730, 756, 691 cm1; 1H  7.98 (1 H, dd, J = 7.8 and 1.1 Hz), 7.65 (1 H, dd, J = 7.7 and 1.0 Hz), 
7.61–7.57 (2 H, m), 7.49 (1 H, td, J = 7.5 and 1.6 Hz), 7.41–7.33 (4 H, m), 3.97 (3 H, s); 13C 
166.63, 133.91, 131.75, 131.66, 130.41, 128.46, 128.29, 127.83, 123.61, 123.22, 94.26, 88.15,
52.14; MS m/z 236 (M+), 221, 205, 193, 176, 165, 151, 150.
2-(1-Propynyl)benzoic Acid (132c).    The following procedure for the preparation of 132c is
representative.  A solution of 3.934 g (22.61 mmol) of 131c in 100.0 mL of THF and 99.0 mL of
1 N NaOH was heated at 50 C for 12 h.  The reaction mixture was cooled in an ice-water bath
and was acidified with dilute HCl.  The organic layer was separated, washed with water, dried
over MgSO4  and concentrated.  The residue was purified by recrystallization from 50% of
diethyl ether in hexanes to afford 132c (2.20 g, 13.75 mmol, 61%) as light yellow solid: IR 2915,
1675, 1284, 754 cm-1; 1H  11.82 (1 H, br s), 8.05 (1 H, dd, J = 8.0 and 1.3 Hz), 7.54 (1 H, dd, J
= 7.9 and 1.4 Hz), 7.48 (1 H, td, J = 7.7 and 1.5 Hz), 7.35 (1 H, td, J = 7.7  and 1.5 Hz), 2.4 (3 H,
s); 13C  171.54, 134.36, 132.36, 131.04, 130.60, 127.29, 124.85, 92.73, 78.13, 4.78; MS m/z 160
(M+), 145, 118, 89, 77, 43; HRMS calcd for C10H8O2 160.0524, found 160.0523.
2-(1-Pentynyl)benzoic Acid (132d).
  A solution of 5.000 g (24.75 mmol) of 131d in 30 mL of
THF and 140 mL of 1 N NaOH was heated at 50 C for 12 h.  The reaction mixture was cooled
in an ice–water bath and was acidified with dilute HCl.  The organic layer was separated, washed
with water, dried over MgSO4, and concentrated.  The residue was purified by recrystallization
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from 50% of diethyl ether in hexanes to afford 4.354 g (23.16 mmol, 94%) of 132d as pale
yellow needles: IR 2962, 2234, 1692, 757 cm1; 1H  11.4 (1 H, br), 8.06 (1 H, dd, J = 7.9 and
1.1 Hz), 7.55 (1 H, dd, J = 7.7 and 1.2 Hz), 7.48 (1 H, td, J = 7.4 and 1.5 Hz), 7.35 (1 H, td, J =
7.4 and 1.5 Hz), 2.47 (2 H, t, J = 7.0 Hz), 1.68 (2 H, sextet, J = 7.4 Hz), 1.09 (3 H, t, J = 7.4 Hz);
13C  171.53, 134.31, 132.34, 131.06, 130.64, 127.27, 124.91, 97.24, 79.00, 21.95, 21.77, 13.50;
MS m/z 188 (M+), 160, 159, 131, 118; HRMS calcd for C12H12O2 188.0837, found 188.0829.
2-[2-(1-Cyclohexenyl)ethynyl]benzoic Acid (132e).  The same procedure was repeated as
described for 132c except that 2.98 g (12.41 mmol) of 131e in 100.0 mL of THF was treated with 
46.0 mL of 1 N NaOH to afford 132e (2.42 g, 10.71 mmol, 86%) as pale yellow needles: IR
2929, 2201, 1694, 752 cm-1; 1H  8.08 (1 H, dd, J = 7.7 and 1.0 Hz), 7.56 (1 H, dd, J = 7.6 and
1.4 Hz), 7.49 (1 H, td, J = 7.3  and 1.4 Hz), 7.36 (1 H, td, J = 7.6 and 1.7 Hz), 6.30 (1 H, m), 2.28
(2 H, m), 2.17 (2 H, m), 1.67 (4 H, m); 13C  171.04, 136.51, 133.94, 132,39, 131.25, 130.32,
127.46, 124.61, 120.79, 97.67, 85.40, 28.78, 25.86, 22.26, 21.45; MS m/z 226 (M+), 197, 181,
165, 141, 105, 67; HRMS calcd for C15H14O2 226.0994, found 226.0992.
2-(Phenylethynyl)benzoic Acid (132f).
  The same procedure was repeated as described for 132c
except that 3.114 g of 18f (13.2 mmol) was used to afford 2.69 g (12.11 mmol, 92%) of 132f as
pale yellow needles: IR 3061, 2210, 1695, 754, 690 cm1;  1H  8.15 (1 H, dd, J = 7.8 and 1.2
Hz), 7.7 (1 H, dd, J = 7.6 and 1.1 Hz), 7.6–7.54 (3 H, m), 7.44 (1 H, td, J = 7.6 and 1.3 Hz),
7.35–7.29 (3 H, m); 13C  171.12, 134.18, 132.60, 131.75, 131.39, 130.46, 128.64, 128.38,
128.00, 124.30, 123.05, 95.39, 87.96; MS m/z 222 (M+), 194, 165.
2-(1-Propynyl)phenyl Isocyanate (133c).  The following procedure for the preparation of 133c
is representative.  To a solution of 2.163 g (15.32 mmol) of 132c in 30 mL of anhydrous benzene
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were added 1.9 mL of triethylamine and 3.0 mL (13.52 mmol) of DPPA.  After 3 h at rt, the
reaction mixture was heated at reflux for 2 h until the nitrogen gas evolution had ceased.  The
reaction mixture was then washed with a saturated NH4Cl solution, water, dried over MgSO4,
and concentrated.  The reside was purified by flash chromatography (silica gel/5% diethyl ether
in hexanes) to afford 133c (1.65 g, 10.51 mmol, 78%)  as a light yellow liquid: IR (neat) 2288,
2240, 1723, 1520, 755 cm-1; 1H  7.37 (1 H, dd, J = 7.6  and 1.7 Hz), 7.21 (1 H, td, J = 7.7  and
1.62 Hz), 7.10 (1 H, td, J = 7.6  and 1.4 Hz), 7.00 (1 H, dd, J = 7.9  and 1.1 Hz), 2.13 (3 H, s);
13C  135.41, 131.76, 128.51, 125.21, 123.26, 121.45, 95.35, 75.67, 4.41; MS m/z 157 (M+), 129,
102, 76, 63, 51; HRMS calcd for C10H7NO 157.0528, found 157.0525.
2-(1-Pentynyl)phenyl Isocyanate (133d).
  To a solution of 3.22 g (17.1 mmol) of 132d in 30
mL of anhydrous benzene were added 2.4 mL of triethylamine and 3.83 mL (17.8 mmol) of
DPPA.  After 3 h at rt, the reaction mixture was heated at reflux for 2 h until the nitrogen gas
evolution had ceased.  The reaction mixture was then washed with a saturated NH4Cl solution,
water, dried over MgSO4, and concentrated. The residue was purified by flash chromatography
(silica gel/3% diethyl ether in hexanes) to afford 2.48 g (13.41 mmol, 78%) of 133d as a
colorless oil: IR (neat) 2244, 1599, 1506, 755 cm1; 1H  7.40 (1 H, dd, J = 7.7 and 1.7 Hz), 7.20
(1 H, td, J = 7.2 and 1.7 Hz), 7.10 (1 H, td, J = 7.5 and 1.5 Hz), 7.00 (1 H, dd, J = 7.9 and 1.2
Hz), 2.50 (2 H, t, J = 7.1 Hz), 1.72 (2 H, sextet, J = 7.2 Hz), 1.10 (3 H, t, J = 7.4 Hz); 13C 
135.10, 131.95, 128.38, 127.38, 125.10, 123.19, 121.52, 99.38, 76.36, 21.62, 21.49, 13.46; MS
m/z 185 (M+), 170, 156, 130, 128; HRMS calcd for C12H11NO 185.0841, found 185.0849.
2-[2-(1-Cyclohexenyl)ethynyl]phenyl Isocyanate (133e).   The same procedure was repeated as
described for 133c except that 2.14 g (9.46 mmol) of 132e was treated with 1.32 mL of
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triethylamine and 2.03 mL (9.46 mmol) of DPPA to afford 133e (1.614 g, 7.24 mmol, 77%) as a
light yellow liquid: IR (neat) 2926, 2256, 1593, 1505, 753 cm-1; 1H  7.41 (1 H, dd, J = 7.7  and
1.7 Hz), 7.21 (1 H, td, J = 7.7  and 1.7 Hz), 7.12 (1 H, td, J = 7.5  and 1.4 Hz), 7.01 (1 H, dd, J =
7.9  and 1.2 Hz), 6.34 (1 H, septet?, J = 1.9 Hz), 2.27 (2 H, m), 2.17 (2 H, m), 1,67 (4 H, m); 13C
 136.53, 134.50, 132.07, 128.66, 127.16, 125.28, 123.39, 121.46, 120.26, 99.44, 82.15, 28.55,
25.81, 22.19, 21.40; MS m/z 223 (M+), 194, 180, 167, 117, 80; HRMS calcd for C15H13NO
223.0997, found 223.0988.
2-(Phenylethynyl)phenyl Isocyanate (133f).
  The same procedure was repeated as described for
133d
 except that 0.542 g of 132f (2.441 mmol) in 15 mL of anhydrous benzene, 0.34 mL of
triethylamine, and 0.54 mL (2.5 mmol) of DPPA were used to afford 0.391 g (1.785 mmol, 73%)
of 133f as a colorless oil:  IR (neat) 2235, 755, 684 cm1; 1H  7.66–7.62 (2 H, m), 7.54 (1 H, dd,
J = 7.8 and 1.6 Hz), 7.41–7.36 (3 H, m), 7.29 (1 H, td, J = 7.7 and 1.7 Hz), 7.18 (1 H, td, J = 7.6
and 1.5 Hz), 7.08 (1 H, dd, J = 7.9 and 1.2 Hz);  13C  134.72, 132.21, 131.42, 129.22, 128.81,
128.34, 127.01, 125.37, 123.51, 122.33, 120.92, 97.40, 84.75; MS m/z 219 (M+), 190, 163.
Aniline 136a.
  To a degassed solution containing 0.702 g of Pd(PPh3)2Cl2 (1.00 mmol), 0.19  g
of CuI (1.00 mmol), 4.60 g of 2-iodoaniline (21.0  mmol), and 80 mL of Et3N was added 1.17
mL of 1,6-heptadiyne (135a, 10.2 mmol).  After 16 h at rt, the reaction mixture was heated at 45
C for 8 h.  Then the reaction mixture was poured into a flask containing 200 mL of a saturated
NH4Cl solution and 100 mL of Et2O.  After filtration, the organic layer was separated, washed
with water, dried over MgSO4, and concentrated.  The residue was purified by flash column
chromatography (silica gel/50% diethyl ether in hexanes) to furnish 2.415 g (8.814 mmol, 86%)
of 136a as a yellow oil: IR (neat) 3467, 3371, 1612, 748 cm1; 1H  7.30 (2 H, dd, J = 8.0 and 1.4
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Hz), 7.13 (2 H, td, J = 8.5 and 1.5 Hz), 6.74–6.69 (4 H, m), 4.21 (4 H, br s, NH), 2.69 (4 H, t, J =
6.9 Hz), 1.94 (2 H, quintet, J = 7.0 Hz), 13C  147.61, 131.92, 128.88, 117.66, 114.06, 108.37,
94.22, 77.77, 27.82, 18.70; MS m/z 274 (M+), 207, 191, 144, 131.
Aniline 136b.
  The same procedure was repeated as described for 136a except that a solution of
1.404 g of Pd(PPh3)2Cl2 (2.00 mmol), 0.38 g of CuI (2.00 mmol), 9.20 g of 2-iodoaniline (42.0
mmol), and 2.404 g (20.0 mmol) of 1,8-nonadiyne (135b) in 160 mL of Et3N was used. 
Purification by column chromatography afforded 5.61 g of 136b (18.6 mmol, 93%) as a yellow
liquid: IR (neat) 3468, 3373, 1613, 748 cm1; 1H  7.30 (2 H, dd, J = 7.4 and 1.2 Hz), 7.12 (2 H,
td, J = 7.7 and 1.5 Hz), 6.72–6.66 (4 H, m), 4.18 (4 H, br s, NH), 2.54 (4 H, t, J = 6.2 Hz), 1.70
(6 H, m); 13C  147.51, 131.80, 128.67, 117.57, 113.96, 108.54, 95.22, 77.13, 28.23, 27.97,
19.38.
Iminophosphorane 137a.
  The reaction mixture of 0.965 g (3.52 mmol) of 136a, 3.12 g (7.39
mmol) of Ph3PBr2, 2.0 mL of anhydrous triethylamine, and 30 mL of anhydrous benzene was
heated under reflux for 5 h.  Triethylammonium bromide was removed by filtration, and the
filtrate was concentrated.  The residue was purified through a short column (silica gel/40%
diethyl ether and 5% ethanol in hexanes) to afford 0.565 g (0.711 mmol, 20%) of 137a as
colorless crystals: IR 1583, 1477, 1435, 694 cm1; 1H  7.81 (12 H, m), 7.44 (18 H, m), 7.32 (2
H, dt, J = 7.7 and 2.1 Hz), 6.84 (2 H, td, J = 7.7 and 1.6 Hz), 6.59 (2 H, t, J = 7.2 Hz), 6.52 (2 H,
d, J = 7.9 Hz), 2.72 (4 H, t, J = 7.2 Hz), 2.07 (2 H, quintet, J = 7.2 Hz); 13C  152.27, 133.94,
132.64 (d, J = 9.8 Hz), 131.56 (d, J = 2.6 Hz), 131.15 (d, J = 99.9 Hz), 128.44 (d, J = 11.9 Hz),
127.68, 121.63 (d, J = 9.3 Hz), 119.39 (d, J = 22.3 Hz), 117.13, 91.67, 81.97, 29.05, 19.68.
Iminophosphorane 137b.
  The same procedure was repeated as described for 137a except that a
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solution of 1.10 g (3.64 mmol)of 136b and 3.224 g (7.64 mmol) of Ph3PBr2 in 2.04 mL of
anhydrous triethylamine and 40 mL of anhydrous benzene was heated under reflux for 4 h. 
Purification by column chromatography afforded 0.882 g (1.07 mmol, 29%) of 137b as a white
solid: IR 1583, 1477, 1436, 717, 694 cm1; 1H  7.85–7.77 (12 H, m), 7.51–7.38 (18 H, m), 7.30
(2 H, dt, J = 7.7 and 2.1 Hz), 6.80 (2 H, td, J = 7.9 and 1.9 Hz), 6.56 (2 H, t, J = 7.42 Hz), 6.47
(2 H, d, J = 7.9 Hz), 2.47 (4 H, t, J = 6.2 Hz), 1.74–1.64 (6 H, m); 13C  152.34, 132.94, 132.70
(d, J = 9.8 Hz), 131.57 (d, J = 2.6 Hz), 131.36 (d, J = 99.9 Hz), 128.44 (d, J = 11.9 Hz), 127.64,
121.58 (d, J = 9.3 Hz), 119.43 (d, J = 22.3 Hz), 117.14, 92.25, 81.50, 28.95, 28.70, 20.05.
Carbodiimide 138a.
  A mixture of 1.096 g (4.00 mmol) of 136a, 3.518 g (8.33 mmol) of
Ph3PBr2, 2.2 mL of anhydrous triethylamine, and 40 mL of anhydrous benzene was heated under
reflux for 5 h.  Triethylammonium bromide was removed by filtration, and the filtrate was
concentrated.  The crude 137a was used directly without further purification.  To the crude 137a
in 20 mL of anhydrous benzene was introduced via cannula a solution of 0.953 g (8.01 mmol) of
phenyl isocyanate in 60 mL of anhydrous benzene under a nitrogen atmosphere at rt.  After 4 h,
the reaction mixture was concentrated in vacuo, and the residue was purified by column
chromatography (silica gel/5% diethyl ether in hexanes) to afford 0.941 g (1.98 mmol, 49%
overall yield from 136a) of 138a as a yellow oil: IR (neat) 2136, 2102, 1590, 1482, 754 cm1; 1H
 7.37 (2 H, dd, J = 7.7 and 1.7 Hz), 7.3–7.18 (10 H, m), 7.13–7.06 (6 H, m), 2.11 (4 H, t, J = 7.2
Hz), 1.48 (2 H, quintet, J = 7.2 Hz); 13C  139.05, 138.78, 133.69, 133.11, 129.34, 128.64,
125.20, 124.33, 124.22, 120.54, 97.51, 77.35, 26.94, 18.93; MS m/z 476 (M+), 359, 277, 194;
HRMS calcd for C33H24N4 476.2001, found 476.2012.
The carbodiimide 138a was also obtained by treatment of the purified 137a with phenyl
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isocyanate.  To 0.156 g of 137a (0.196 mmol) in 10 mL of anhydrous benzene was introduced
via cannula a solution of 0.047 g of phenyl isocyanate (0.39 mmol) in 5 mL of anhydrous
benzene under a nitrogen atmosphere at rt.  After 4 h, the reaction mixture was concentrated in
vacuo, and the residue was purified by flash chromatography (silica gel/2% diethyl ether in
hexanes) to afford 0.067 g (0.141 mmol, 72%) of 138a.
Carbodiimide 138b.
  The same procedure was repeated as described for 138a except that a
mixture of 0.305 g (1.01 mmol) of 136b, 0.895 g (2.12 mmol) of Ph3PBr2, 0.57 mL of anhydrous
triethylamine, and 30 mL of anhydrous benzene was heated under reflux for 5 h.  To the crude
137b
 in 10 mL of anhydrous benzene was introduced via cannula a solution of 0.240 g (2.02
mmol) of phenyl isocyanate in 30 mL of anhydrous benzene under a nitrogen atmosphere at rt. 
After 4 h, the reaction mixture was concentrated, and the residue was purified by column
chromatography (silica gel/2–5% diethyl ether in hexanes) to afford 0.276 g (0.55 mmol, 54%
overall yield from 136b) of 138b as a colorless liquid: IR (neat) 2135, 1591, 1482 cm1; 1H 
7.38 (2 H, dd, J = 7.7 and 1.7 Hz), 7.33–7.19 (10 H, m), 7.16–7.03 (6 H, m), 2.02 (4 H, t, J = 6.4
Hz), 1.29 (6 H, m); 13C  139.19, 138.73, 133.75, 133.05, 129.34, 128.50, 125.21, 125.14,
124.33, 124.25, 120.76, 98.66, 76.91, 28.03, 27.68, 19.51; MS m/z 504 (M+), 310, 281, 245, 231,
194; HRMS calcd for C35H28N4 504.2314, found 504.2334.
Indoloquinoline 139a.
  A solution of 0.246 g (0.52 mmol) of 138a in 80 mL of p-xylene was
heated under reflux for 5 h.  After the reaction mixture was cooled to rt, the yellow precipitate
was separated by centrifugation.  After two cycles of heating the precipitate in 20 mL of p-xylene
at 60 C followed by centrifugation and decanting the supernatant liquid, the remaining solid
was pumped to dryness in vacuo to afford 0.183 g (0.384 mmol, 74 %) of 139a as a yellow solid:
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IR 1699, 870, 755 cm1; 1H (DMSO-d6)  11.69 (2 H, br s, NH), 8.56 (2 H, d, J = 8.3 Hz), 7.99
(2 H, d, J = 8.4 Hz), 7.75–7.68 (4 H, m), 7.51 (2 H, t, J = 7.6 Hz), 7.40 (4 H, d, J = 3.9 Hz), 6.95
(2 H, m, J = 4.2 Hz), 3.96 (4 H, t, J = 7.3 Hz), 2.33 (2 H, m); 13C (DMSO-d6)  153.02, 147.01,
143.06, 141.86, 129.11, 128.23, 128.03, 124.90, 123.72, 123.45, 123.26, 120.70, 119.95, 116.00,
111.28, 30.16, 28.28; MS m/z 476 (M+), 401, 375, 277, 245, 232; HRMS calcd for C33H24N4
476.2001, found 476.2025.
Indoloquinoline 139b.
  The same procedure was repeated as described for 139a except that
0.216 g (0.428 mmol) of 138b in 15 mL of p-xylene was used to afford 0.167 g (0.33 mmol,
77%) of 139b as a yellow solid: IR (KBr) 3442, 1613, 742 cm1; 1H (DMSO-d6)  11.69 (2 H, s),
8.31 (2 H, d, J = 8.6 Hz), 8.21(2 H, d, J = 7.7 Hz), 7.96 (2 H, d, J = 8.3 Hz), 7.70 (2 H, t, J = 7.6
Hz), 7.56–7.43 (6 H, m), 7.27 (2 H, td, J = 7.7 and 1.8 Hz), 3.69 (4 H, br), 1.93 (6 H, br); 13C
(DMSO-d6)  153.06, 146.95, 143.67, 141.93, 128.97, 128.15, 128.07, 124.70, 123.84, 123.26,
123.13, 120.97, 120.34, 115.89, 111.39, 30.30, 29.99, 28.74; MS m/z 504 (M+), 245, 231; HRMS
calcd for C35H28N4 504.2314, found 504.2292.
Carbodiimide 140.
  To 2.876 g (5.88 mmol) of 109g in 10 mL of anhydrous benzene was
introduced via cannula a solution of 0.471 g (2.94 mmol) of 1,4-phenylene diisocyanate in 60
mL of anhydrous benzene under a nitrogen atmosphere at rt.  After 2 h, the reaction mixture was
concentrated in vacuo, and the residue was purified by column chromatography (silica gel/2%
diethyl ether in hexanes) to afford 0.75 g (1.29 mmol, 44%) of 140 as a colorless liquid: IR 2103,
836, 755 cm1; 1H  7.39 (2 H, dm, J = 7.7 and 2 Hz), 7.22 (2 H, td, J = 6.9 and 1.7 Hz), 7.17 (4
H, s), 7.10 (4 H, t, J = 7.2 Hz), 2.13 (4 H, t, J = 6.9 Hz), 1.43 (4 H, quintet, J = 7.2 Hz), 1.24 (20
H, br), 0.87 (6 H, t, J = 6.6 Hz); 13C  138.56, 136.28, 133.70, 133.10, 128.48, 125.33, 125.12,
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124.36, 120.91, 99.10, 76.79, 31.83, 29.19, 29.12, 28.99, 28.36, 22.66, 19.80, 14.11.
Indoloquinoline 144.
  To a solution of 0.14 g (0.286 mmol) of 109g in 10 mL of anhydrous p-
xylene was added via cannula a solution of 0.023 g (0.144 mmol) of 1,4-phenylene diisocyanate
in 50 mL of anhydrous p-xylene under a nitrogen atmosphere at rt.  After 1 h, the reaction
mixture was heated under reflux for 6 h.  The reaction mixture was then concentrated, and the
residue was purified by column chromatography (silica gel/20% diethyl ether and 5% ethanol in
hexanes) to afford 0.055 g (0.094 mmol, 66%) of 144 as a yellow solid: IR 1600, 818, 735 cm1;
1H  11.08 (2 H, s), 8.28 (2 H, d, J = 7.9 Hz), 8.23 (2 H, s), 7.74 (2 H, d, J = 8.1 Hz), 7.62 (2 H, t,
J = 7.4 Hz), 7.43 (2 H, t, J = 7.3 Hz), 4.00 (2 H, ddd, J = 12.9, 8.7, and 4.2 Hz), 3.74 (2 H, dt, J =
13.4 and 8.0 Hz), 1.79 (2 H, br), 1.62 (2 H, br), 1.15–0.82 (20 H, m), 0.67 (6 H, t,
 J = 7.0 Hz); 1H
(DMSO-d6)  11.96 (2 H, s), 8.23 (2 H, d, J = 8.1 Hz), 7.90 (2 H, s), 7.58 (2 H, d, J = 7.3 Hz),
7.53 (2 H, t, J = 8.1 Hz), 7.32 (2 H, t, J = 6.9 Hz), 3.96 (2 H, m), 3.59 (2 H, m), 1.48 (2 H, br),
1.22 (2 H, br), 1.05–0.56 (26 H, m); 13C  152.01, 145.65, 140.35, 130.17, 126.97, 123.39,
121.49, 120.40, 119.74, 115.05, 111.28, 33.89, 31.58, 29.90, 29.18, 28.87, 22.41, 13.94; 13C
(DMSO-d6)  151.98, 146.07, 144.40, 140.96, 130.85, 127.20, 123.61, 120.94, 120.37, 119.43,
113.94, 111.59, 32.70, 31.47, 29.48, 28.66, 28.38, 28.24, 22.33, 14.31; MS m/z 582 (M+), 469,
384, 371, 272; HRMS calcd for C40H46N4 582.3722, found 582.3698.
Iminophosphorane 199.  The reaction mixture of 0.753 g (8.0 mmol) of 4-aminopyridine, 3.72
g (8.8 mmol) of Ph3PBr2, 2.46 mL of anhydrous triethylamine, and 60 mL of anhydrous benzene
was heated under reflux for 5 h.  Triethylammonium bromide was removed by filtration, and the
filtrate was concentrated.  The residue was purified through a short column (silica gel/20%
ethanol in diethyl ether) to furnish 199 (2.096 g, 5.921 mmol, 74%) as a light brown solid: IR
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1585, 1495, 1360, 1109, 719, 694 cm-1; 1H  8.04 (2 H, d, J = 5.0 Hz), 7.58 (1 H, m), 6.59 (2 H,
d, J = 5.7 Hz); 13C  158.74, 149.41, 132.46, 132.13, 130.28, 129.54, 128.80, 118.71; MS m/z
355 (MH+), 279, 257, 201, 183, 120; HRMS calcd for C23H20N2P (M+1) 355.1364, found
355.1386.
Aza-Ellipticine Analogue 204c.  The following procedure for the preparation of 204c is
representative.  To 0.354 g (1.0 mmol) of the iminophosphorane 199 in 40 mLof anhydrous p-
xylene was introduced via cannula a solution of 0.157 g (1.0 mmol) of 2-(1-propynyl)phenyl
isocyanate 133c in 10.0 mL of anhydrous p-xylene under a nitrogen atmosphere at rt.  After 1.5
h, the reaction mixture was heated under reflux for 15 h.  The reaction mixture was then
concentrated.  After three cycles of washing the precipitate in 40.0 mL of diethyl ether followed
by centrifugation and decanting the supernatant liquid, the remaining solid was pumped to
dryness in vacuo to afford 204c (0.114 g, 0.49 mmol, 49%) as a brown solid: IR 1604, 1569,
1462, 1393, 1237, 1032, 825, 740, 718 cm-1; 1H  9.68 (1 H, s), 8.73 (1 H, d, J = 5.9 Hz), 8.29 (1
H, d, J = 7.9 Hz), 7.85 (1 H, d, J = 5.9 Hz), 7.55 (2 H, m), 7.38 (1 H, td, J = 8.1 and 1.5 Hz), 3.31
(3 H, s); 13C  (DMSO-d6) 154.96, 150.21, 149.35, 145.79, 141.82, 140.89, 129.33, 128.65,
124.56, 121.52, 120.98, 120.82, 117.73, 111.71, 14.84; MS m/z 233 (M+), 205, 179, 152, 133,
116, 98, 77, 55; HRMS calcd for C15H11N3 233.0953, found 233.0963.
Aza-Ellipticine Analogue 204d.  The same procedure was repeated as described for 204c except
that to 0.354 g (1.0 mmol) of the iminophosphorane 199 in 40 mL of anhydrous p-xylene was
treated with a solution of 0.185 g (1.0 mmol) of 2-(1-pentynyl)phenyl isocyanate 133d in 10.0
mL of anhydrous p-xylene.  Purification by flash column chromatography (silica gel/5% ethanol
and 20% diethyl ether in hexanes) afforded 204d (0.133 g, 0.51 mmol, 51%) as a brown solid: IR
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2870, 1602, 1462, 817, 734 cm-1; 1H  12.09 (1 H, br s, NH), 9.59 (1 H, s), 8.60 (1 H, d, J = 5.9
Hz), 8.06 (1 H, d, J = 7.9 Hz), 7.77 (1 H, d, J = 5.6 Hz), 7.42 (2 H, s), 7.31 (1 H, m), 3.62 (2 H, t,
J = 7.3 Hz); 13C  (DMSO-d6) 155.14, 155.00, 150.08, 149.48, 145.81, 145.15, 141.89, 141.74,
128.68, 124.18, 121.14, 120.91, 119.42, 117.20, 111.81, 29.71, 23.68, 14.67; MS m/z 261 (M+),
232, 205, 179, 127, 77; HRMS calcd for C17H15N3 261.1266, found 261.1260;  Anal. Calcd for
C17H15N3: C, 78.13; H, 5.79; N, 16.08.  Found: C, 78.01; H, 5.78; N, 16.04.
Aza-Ellipticine Analogue 204e.  The same procedure was repeated as described for 204c except
that 0.361 g (1.02 mmol) of 199 was treated with 0.227 g (1.02 mmol) of 204e.  Purification by
flash column chromatography (silica gel/10% ethanol and 20% diethyl ether in hexanes) afforded
204e (0.253 g, 0.846 mmol, 83%) as yellow crystals: IR 3072, 2922, 1596, 1404, 1233, 822, 726
cm-1; 1H  11.12 (1 H, br s, NH), 9.50 (1 H, s), 8.73 (1 H, d, J = 5.9 Hz), 8.14 (1 H, d, J = 7.9
Hz), 7.91 (1 H, d, J = 5.9 Hz), 7.54 (2 H, d, J = 3.9 Hz), 7.32 (1 H, sextet, J = 3.9 Hz), 6.06 (1 H,
s), 2.46 (4 H, m), 2.04 (4 H, m); 13C  155.36, 151.28, 149.24, 146.35, 145.90, 140.88, 132.23,
129.56, 128.40, 123.52, 121.03, 119.84, 119.16, 116.54, 111.05, 29.33, 25.44, 22.97, 22.07; MS
m/z 299 (M+), 270, 256, 244, 219, 149, 128; HRMS calcd for C20H17N3 299.1422, found
299.1417.
Aza-Ellipticine Analogue 204f.  The same procedure was repeated as described for 204c except
that 0.522 g of 199 (1.474 mmol) was treated with 0.323 g of phenyl isocyanate 133f (1.474
mmol).  Purification by flash column chromatography (silica gel/10% ethanol and 20% diethyl
ether in hexanes) afford 204f (0.253 g, 0.86 mmol, 58%) as a light yellow solid: IR 3063, 1610,
1594, 1387, 1242, 731, 613 cm-1; 1H  13.62 (1 H, br s, NH), 8.94 (1 H, s), 8.56 (1 H, d, J = 5.9
Hz), 7.81 (1 H, d, J = 5.9 Hz), 7.68 (3 H, m), 7.41 (2 H, dd, J = 6.5 Hz and 1.2 Hz), 7.18( 1 H, d,
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J = 7.7 Hz), 7.08 (2 H, dd, J = 15.6 Hz and 7.3 Hz), 6.91 (1 H, t, J = 7.6 Hz); 13C  154.71,
151.26, 148.78, 145.53, 143.32, 141.20, 134.08, 129.39, 129.20, 128.96, 128.34, 122.90, 120.32,
120.27, 119.17, 118.91, 117.48, 110.98; MS m/z 295 (M+),191, 84, 43; HRMS calcd for C20H13N3
295.1111, found 295.1124.
Iminophosphorane 205.  The same procedure was repeated as described for 199 except that a
mixture of 1.412 g (15.0 mmol) of 3-aminopyridine, 7.281 g (17.2 mmol) of Ph3PBr2, 4.61 mL of
anhydrous triethylamine, and 80 mL of anhydrous benzene was heated under reflux for 5 h.  The
reaction mixture was purified by flash chromatography (silica gel/10% ethanol in hexanes) to
furnish 205 (4.04 g, 11.41 mmol, 76%) as a brown solid: IR 3054, 2205, 1567, 1346, 1106, 910,
713, 694, 571 cm-1; 1H  8.11 (1 H, d, J = 2.7 Hz), 7.87 (1 H, dd, J = 5.6  and 1.4 Hz), 7.73 (6 H,
m), 7.48 (9 H, m), 7.04 (1 H, d, J = 8.2 Hz), 6.91 (1 H, dd, J = 8.2 and 4.6 Hz); 13C  147.56,
145.07, 138.33, 132.44, 131.91, 130.29, 129.36, 128.72, 123.28; MS m/z 355 (MH+), 279, 201,
183; HRMS calcd for C23H20N2P (M+1) 355.1364, found 355.1368.    
Aza-Ellipticine Analogue 209d and Aza-Ellipticine Analogue 212d.  The following procedure
for the preparation of 209d and 212d is representative. To 0.354 g (1.0 mmol) of the
iminophosphorane 205 in 40.0 mL of anhydrous p-xylene was introduced via cannula a solution
of 0.185 g (1.0 mmol) of 2-(1-pentynyl)phenyl isocyanate 133d in 10.0 mL of anhydrous p-
xylene under a nitrogen atmosphere at rt.  After 1.5 h, the reaction mixture was heated under
reflux for 15 h.  The reaction mixture was then concentrated, and the residue was purified by
column chromatography (silica gel/10% ethanol and 20% diethyl ether in hexanes) to afford
209d (0.174 g, 0.667 mmol, 67%) and 212d (0.013 g, 0.0498 mmol, 5%) as brown solids.  209d:
IR 1613, 1457, 817, 764, 720 cm-1; 1H  11.32 (1 H, br s, NH), 8.91 (1 H, dd, J = 4.2 and 3.1
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Hz), 8.27 (1 H, dd, J = 8.4 and 1.4 Hz), 8.12 (1 H, d, J = 7.9 Hz), 7.50 (3  H, m), 7.30 (1 H, m),
3.28 (2 H, t, J = 8.0 Hz), 1.91 (2 H, sextet, J = 7.7 Hz), 1.20 (3 H, t, J = 7.4 Hz); 13C  152.66,
146.54, 146.35, 141.38, 141.17, 139.48, 134.58, 128.08, 124.06, 123.42, 121.47, 120.71, 119.09,
110.86, 29.55, 22.76, 14.72; MS m/z 261 (M+), 246, 233, 219, 130; HRMS calcd for C17H15N3
261.1266, found 261.1265;  Anal. Calcd for C17H15N3: C, 78.13; H, 5.79; N, 16.08.  Found: C,
78.27; H, 5.79; N, 16.05.  212d: IR 2922, 1614, 1472, 1263, 797, 726 cm-1; 1H  9.71 (1 H, br s,
NH), 9.56 (1 H, s), 8.60 (1 H, d, J = 5.9 Hz), 8.22 (1 H, d, J = 7.6 Hz), 8.06 (1 H, d, J = 5.9 Hz),
7.59 (2 H, m), 7.38 (1 H, m), 3.64 (2 H, t, J = 3.9 Hz), 1.96 (2 H, sextet, J = 7.7 Hz); 13C 
(DMSO-d6) 153.55, 152.30, 142.68, 140.13, 129.33, 126.32, 124.70, 120.89, 120.28, 117.46,
111.74, 30.01, 23.14, 14.68; MS m/z 261 (M+), 232, 205, 151; HRMS calcd for C17H15N3
261.1266, found 261.1261.
Aza-Ellipticine Analogue 209e and Aza-Ellipticine Analogue 212e.  The same procedure was
repeated as described for 209d and 212d except that 0.233 g 133e (1.0 mmol) was treated with
0.354 g (1.0 mmol) of the iminophosphorane 205.  Purification by flash column chromatography
(silica gel/10% ethanol and 20% diethyl ether in hexanes) afford 209e (0.233 g, 0.78 mmol, 78%)
and 212e (0.0258 g, 0.0862 mmol, 9%) both as yellow needle.  209e: IR 3065, 2923, 1606, 1398,
905, 729, 603 cm-1; 1H  10.73 (1 H, br s, NH), 8.97 (1 H, dd, J = 3.1 and 1.7 Hz), 8.39 (1 H, dd,
J = 7.6 and 1.7 Hz), 8.33 (1 H, d, J = 7.9 Hz), 7.62 (1 H, dd, J = 8.7 and 4.2 Hz), 7.50 (2 H, m),
7.27 (1 H, m), 6.08 (1 H, m), 2.39 (1 H, d, J = 16.2 Hz), 2.38 (3 H, m), 2.01 (4 H, m); 13C 
153.28, 146.61, 146.54, 141.85, 141.20, 138.91, 134.35, 133.82, 128.06, 127.65, 123.78, 122.93,
121.17, 120.07, 118.51, 110.78, 29.16, 25.44, 22.98, 22.09; MS m/z 299 (M+), 270, 244, 226,
197, 165, 115, 77, 57; HRMS calcd for C20H17N3 299.1422, found 299.1425;  Anal. Calcd for
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C20H17N3: C, 80.24; H, 5.72; N, 14.04.  Found: C, 80.11; H, 5.71; N, 13.91.  212e: IR 2930,
1607, 1452, 1406, 1375, 1242, 1211, 733 cm-1; 1H  9.51 (1 H, s), 9.34 (1 H, br s, NH), 8.56 (1
H, d, J = 5.9 Hz), 8.18 (1 H, d, J = 7.9 Hz), 7.92 (1 H, d, J = 5.9 Hz), 7.56 (2 H, m), 7.31 (1 H,
td, J = 7.9 and 1.5 Hz), 6.02 (1 H, m), 2.46 (4 H, m), 2.01 (4 H, m); 13C  153.90, 151.00,
143.97, 141.85, 141.15, 140.03, 132.61, 129.25, 129.14, 126.38, 123.98, 120.71, 120.46, 118.93,
118.35, 111.18, 28.79, 25.42, 22.99, 22.10; MS m/z 299 (M+), 270, 257, 244, 190, 155, 133, 119,
85, 71, 57; HRMS calcd for C20H17N3 299.1422, found 299.1418.
Aza-Ellipticine Analogue 209f and Aza-Ellipticine Analogue 212f.  The same procedure was
repeated as described for 209d and 212d except that 0.219 g (1.00 mmol) of 133f was treated
with 0.354 g (1.0 mmol) of iminophosphorane 205.  Purification by flash column
chromatography (silica gel/10% ethanol and 20% diethyl ether in hexanes) afforded 209f (0.220
g, 0.75 mmol, 75%) and 212f (0.050 g, 0.17 mmol, 17%) both as a yellow solid.  209f: IR 3061,
1611, 1402, 730, 699, 619 cm-1; 1H  9.55 (1 H, br s, NH), 8.93 (1 H, dd, J = 4.8 and 1.7 Hz),
8.43 (1 H, dd, J = 7.6 and 1.7 Hz), 7.65 (6 H, m), 7.48 (2 H, d, J = 3.6 Hz), 7.24 (1 H, d, J = 8.1
Hz), 7.04 (1 H, sextet, J = 4.1 Hz); 13C  152.67, 147.60, 143.60, 141.61, 141.55, 139.24, 135.54,
134.29, 129.69, 128.70, 128.64, 123.86, 123.31, 121.04, 120.39, 119.53, 110.80; MS m/z 294
(M-1)+, 281, 207, 73, 44; HRMS calcd for C20H12N3 294.1031, found 294.1034.  Anal. Calcd for
C20H13N3: C, 81.34; H, 4.44; N, 14.23.  Found: C, 80.58; H, 4.39; N, 14.14.  212f: IR 3056, 1611,
1377, 728, 701 cm-1; 1H  10.05 (1 H, br s, NH), 9.62 (1 H, s), 8.50 (1 H, d, J = 5.9 Hz), 7.69 (3
H, m), 7.57 (5 H, m), 7.20 (1 H, d, J = 8.1 Hz), 7.05 (1 H, td J = 7.6 and 1.5 Hz); 13C  153.58,
151.08, 141.96, 141.28, 141.06, 141.06, 140.45, 134.81, 129.37, 129.29, 129.22, 129.13, 126.82,
123.86, 120.48, 120.31, 119.91, 118.60, 111.07; MS m/z 295 (M+), 268, 242, 207, 44; HRMS
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calcd for C20H13N3 295.1109, found 295.1107.
Triflate 214.  A solution of 0.547 g (3.0 mmol) of methyl 4-methoxysalicylate and 1.53 mL of
pyridine (1.89 mmol) at 0 C was treated dropwise with 0.555 mL (3.34 mmol) of
trifluoromethanesulfonic anhydride (triflic anhydride).  After 5 min of stirring at 0 C followed
by an additional 2 h of stirring at rt, the reaction mixture was heated at 40 C for 24 h.  The
reaction mixture was then poured into a flask containing 20 mL of H2O and 20 mL of Et2O.  The
organic layer was separated,  washed with water, 10% aq HCl, H2O and saturated NaCl, dried
over MgSO4,  and concentrated.  The residue was purified by flash column chromatography
(silica gel/20% diethyl ether in hexanes) to furnish 214 (0.923 g, 2.94 mmol, 98%) as a pale
yellow liquid: IR (neat) 1727, 1618, 1427, 1277, 1210, 1142, 832 cm-1; 1H  8.04 (1 H, d, J = 9.0
Hz), 6.96 (1 H, dd, J = 8.8 and 2.4 Hz), 6.76 (1 H, d, J = 2.2 Hz), 3.92 (3 H, s), 3.88 (3 H, s); 13C
 163.94, 163.90, 149.56, 134.06, 121.03, 116.31, 116.22, 113.35, 108.84, 55.95, 52.26; MS m/z
314 (M+),283, 219, 153, 125, 107, 79, 69, 51; HRMS calcd for C10H9F3O6S 314.0072, found
314.0086.
Methyl 4-methoxyl-2-(1-propynyl)benzoate (215).  The same procedure was repeated as
described for 131c except that 2.10 g of Pd (PPh3)4Cl2 (3.0 mmol), 0.57 g of CuI (3.0 mmol),
9.08 g of triflic salicylate 214 (29 mmol), and 16.5 mL of N,N-diisopropylethylamine (95 mmol)
in 120 mL of DMF were treated with 1300 mL of gaseous propyne (58 mmol) to afford 215
(4.983 g, 24.4 mmol, 84%) as a light yellow liquid: IR (neat) 2949, 2235, 1727, 1598, 1261, 858,
779, 614 cm-1; 1H  7.88 (1 H, d, J = 8.7 Hz), 6.99 (1 H, d, J = 2.5 Hz), 6.82 (1 H, dd, J = 8.8 and
2.7 Hz), 3.87 (3 H, s), 3.82 (3 H, s), 2.13 (3 H, s); 13C  166.00, 161.75, 132.13, 126.48, 123.60,
118.54, 113.41, 91.27, 78.35, 55.17, 51.57, 4.54; MS m/z 204 (M+), 189, 173, 161, 145, 102, 76;
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HRMS calcd for C12H12O3 204.0787, found 204.0796.
4-Methoxyl-2-(1-propynyl)benzoic Acid (216).  The same procedure was repeated as described
for 132c except that 215 (0.726 g, 3.56 mmol) in 10 mL of THF was treated with 20.4 mL of 1 N
NaOH to afford 216 (0.261 g, 1.374 mmol, 39%) as a white solid: IR (neat) 1671, 1594, 1210,
849, 778, 646 cm-1; 1H  8.05 (1 H, d, J = 9.0 Hz), 7.02 (1 H, d, J = 2.5 Hz), 6.88 (1 H, dd, 8.8
and 2.7 Hz), 3.86 (3 H, s), 2.15 (3 H, s); 13C  169.57, 162.62, 133.55, 126.49, 122.80, 118.78,
114.04, 93.19, 78.25, 55.53, 4.84; MS m/z 190 (M+), 173, 147, 135, 119, 91, 83, 63; HRMS calcd
for C11H10O3 190.0630, found 190.0625.
4-Methoxyl-2-(1-propynyl)phenyl Isocyanate (217).  The same procedure was repeated as
described for 133c except that 0.158 g (0.832 mmol) of 216 was treated with 0.12 mL of
triethylamine and 0.185 mL (0.832 mmol) of DPPA to afford 217 (0.086 g, 0.46 mmol, 55%) as
a light yellow liquid: IR (neat) 2262, 1513, 1204, 1032, 812, 716 cm-1; 1H  6.92 (1 H, d, J = 9.0
Hz), 6.90 (1 H, d, J = 3.9 Hz), 6.75 (1 H, dd, J = 8.7  and 3.1 Hz), 3.77 (3 H, s), 2.12 (3 H, s); 13C
 156.75, 128.23, 127.30, 124.16, 122.10, 116.34, 114.91, 95.13, 75.73, 55.53, 4.47; MS m/z 187
(M+), 172, 144, 116, 89, 63, 52; HRMS calcd for C11H9NO2 187.0633, found 187.0640. 
Aza-Ellipticine Analogue 218.  The same procedure was repeated as described for 204c except
that 0.157 g (0.445 mmol) of 199 was treated with 0.076 g (0.404 mmol) of 217.  After three
cycles of washing with diethyl ether, the solid was refluxed in 40 mL of benzene for 1 h.  Then
the mixture was cooled to rt followed by centrifugation and decanting the supernatant liquid. 
The remaining solid was pumped to dryness in vacuo to afford 218 (0.035 g, 0.133 mmol, 33%)
as a brown solid: IR 3077, 1603, 1578, 1481, 1298, 1212, 1151, 811 cm-1; 1H  (DMSO-d6) 11.92
(1 H br s, NH), 9.72 (1 H, s), 8.62 (1 H, d, J = 6.2 Hz), 7.86 (1 H, d, J = 2.2 Hz), 7.80 ( 1 H, d, J
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= 5.9 Hz), 7.47 (1 H, d, J = 8.7 Hz), 7.24 (1 H, dd, J = 8.7 and 2.5 Hz), 3.91 (3 H, s), 3.29 (3 H,
s); 13C  (DMSO-d6) 155.76, 154.77, 150.19, 148.58, 142.12, 142.03, 136.13, 129.83, 121.79,
121.65, 118.51, 116.84, 112.57, 108.88, 56.40, 14.99; MS m/z 263 (M+), 248, 220, 192, 146,
111, 75, 57; HRMS calcd for C16H13N3O 263.1059, found 263.1051.
Aza-Ellipticine Analogue 219 and Aza-Ellipticine Analogue 220.  The same procedure was
repeated as described for 204d except that 0.056 g (0.299 mmol) of 217 was treated with 0.117 g
(0.329 mmol) of the iminophosphorane 205.  Purification by washing three times of the crude
with 30 mL of Et2O afforded 219 (0.034 g, 0.128 mmol, 43%) as a yellow solid.  The mother
liquid was pumped to dryness in vacuo and was further purified by flash column chromatography
(silica gel/10% ethanol and 20% diethyl ether in hexanes) to afford 220 (0.0031 g, 0.012 mmol,
4%) as a yellow solid.  219: IR 3075, 2989, 1582, 1490, 1463, 1209, 831, 788, 696 cm-1; 1H 
8.95 (1 H, d, J = 3.1 Hz), 8.34 (1 H, d, J = 8.1 Hz), 7.78 (1 H, d, J = 2.0 Hz), 7.63 (1 H, dd, J =
4.1 and 4.5 Hz), 7.44 (1 H, d, J = 8.7 Hz), 7.18 (1 H, dd, J = 2.2 and 6.5 Hz), 3.96 (3 H, s), 3.35
(3 H, s); 1H  (DMSO-d6) 11.78 (1 H, s), 8.91 (1 H, dd, J = 1.5 and 2.5 Hz), 8.34 (1 H, dd, J =
1.3 and 7.3 Hz), 7.80 (1 H, d, J = 2.5 Hz), 7.74 (1 H, dd, J = 3.9 and 8.4 Hz), 7.46 (1 H, d, J =
8.7 Hz), 7.22 (1 H, J = 2.4 and 7.6 Hz), 3.91 (3 H, s), 3.28 (3 H, s); 13C  (DMSO-d6) 154.31,
152.56, 146.50, 141.28, 141.04, 138.77, 136.63, 135.40, 124.19, 121.84, 119.54, 116.82, 112.26,
108.50, 56.33, 14.01; MS m/z 263 (M+), 248, 220, 192, 166, 131, 110, 96, 78, 51; HRMS calcd
for C16H13N3O 263.1059, found 263.1052. 220: 1H  (DMSO-d6) 12.23 (1 H, s), 9.69 (1 H, s),
8.69 (2 H, s), 7.96 (1 H, d, J = 2.2 Hz), 7.56 (1 H, d, 8.7 Hz), 7.36 (1 H, dd, J = 2.2 and 6.5 Hz),
3.94 (3 H, s), 3.28 (3 H, s); MS m/z (M+) 263, 248, 221, 220; HRMS calcd for C16H13N3O
263.1059, found 263.1057.
98
 References 
1.  Horning, E. C. Chem. Rev. 1943, 33, 89.
2.  Bartmess, J. E.; Griffith, S. S. J. Am. Chem. Soc. 1990, 112, 2931-2936.
3.  (a) Gajewski, J. J.; Gortva, A. M. J. Am. Chem. Soc. 1982, 104, 334-335. (b) Gajewski, J. J.;    
     Gortva, A. M. J. Org. Chem. 1989, 54, 373-378.
4.  Hoffmann, H. M. R. Angew. Chem., Int. Ed. Engl. 1969, 8, 556-557.
5.  (a) Hasselmann, D.; Loosen, K. Angew. Chem., Int. Ed. Engl. 1978, 17, 606-608. 
     (b) Kopecky, K. R.; Lau, M.-P. J. Org. Chem. 1978, 43, 525-526.
6.  Pryor, W. A.; Graham, W. D. J. Org. Chem. 1978, 43, 770-772.
7.  (a) Bailey, W. J.; Baylouny, R. A. J. Org. Chem. 1962, 27, 3476-3478. (b) Graham, W. D.;      
     Green, J. G.; Pryor, W. A. J. Org. Chem. 1974, 44, 907-914.
8.  (a) Brinker, U. H.; Fleischhauer, I. Angew. Chem., Int. Ed. Engl. 1979, 18, 396-397. 
     (b) Andemichael, Y. W.; Wang, K. K. J. Org. Chem. 1992, 57, 796-798.
9.  Zweifel, G.; Backlund, S. J. J. Organomet. Chem. 1978, 156, 159-170.
10. (a) Ruitenberg, K.; Meijer, J.; Vermeer, P. J. Organomet. Chem. 1981, 217, 267-271. 
      (b) Baker, C. S. L.; Landor, P. D.; Landor, S. R. J. Chem. Soc 1965, 4659-4664.
11. Brown, H. C.; Mandal, A. K.; Kulkarni, S. U. J. Org. Chem. 1977, 42, 1392-1398.
12. Okamura, W. H.; Peter, R.; Reischl, W. J. Am. Chem. Soc. 1985, 107, 1034-1041.
13. This work was finished by Junkai Liao in our group.
14. Vermeer, P.; Meijer, J.; Brandsma, L. Rec Trav. Chim. Pays-Bas 1975, 94, 112-114.
15. Jeffery, T. J. Chem. Soc., Chem. Commun. 1988, 909-910.
16. (a) Oppolzer, W. Synthesis 1978, 793. (b) Oppolzer, W. Heterocycles 1980, 14, 1615.
99
      (c) Funk, R. L. ; Vollhardt, K. P. C. Chem. Soc. Rev. 1980, 9, 41. (d) McCullough, J. J. Acc.    
       Chem. Res. 1980, 13, 270. (e) Magnus, P.; Gallagher, T; Brown, P.; Pappalardo, P. Acc.         
       Chem. Res. 1984, 17, 35. (f) Fallis, A.G.; Can. J. Chem. 1984, 62, 183. (g) Charlton, J. L.;     
       Alauddin, M. M. Tetrahedron 1987, 43, 2873. (h) Pindur, U; Erfanian-Abdoust, H. Chem.     
       Rev. 1989, 89, 1681. (i)Martin, N.; Seoane, C.; Hanack, M. Org. Prep. Proc. Intl. 1991,         
       23, 237. (j) Oppolzer, W.  in: Trost, B. M.; Fleming, I. (Eds), Comprehensive Organic            
       Synthesis, Pergamon Press, New York, 1991, Vol.5 p. 385. (k) Chou, T.-s. Rev.                       
      Heteroatom. Chem. 1993, 8, 65.
17. Cava, M. P.; Deana, A. A. J. Am. Chem. Soc. 1959, 81, 4266
18. Ito, Y.; Nakatsuka, M.; Saegusa, T. J. Am. Chem. Soc. 1980, 102, 863.
19. (a) Nicolaou, K. C.; Barnette, W. E.; Ma, P. J. Org. Chem. 1980, 45, 1463. (b) Oppolzer, W.   
      Roberts, D. A.; Bird, T.G.C. Helv. Chem. Acta. 1979, 62, 2017.
20. (a) Lenihan, B. D.; Shechter, H.  J. Org. Chem. 1998, 63, 2072. (b) Andemichael, Y.W.; Gu,   
     Y. G.; Wang, K. K. J. Org. Chem. 1992, 57,  794. (c) de Fonseka, K. K.; McCullough, J. J.;     
     Yarwood, A. J.  J. Am. Chem. Soc. 1979, 101,  3277.
21. Jarvis, W. F.; Hoey, M. D.; Finocchio, A. L.; Dittmer, D. C. J. Org. Chem. 1988, 53, 5750  
22. Sammes, P. G. J. Tetrahedron 1976, 32,  405.
23. Quinkert, G.; Stark, H. Angew. Chem., Int. Ed. Engl. 1983, 22, 637.
24. Hornback, J. M.; Barrows, R. D. J. Org. Chem. 1982, 47, 4285.
25. (a) Wang, K. K. Chem. Rev. 1996, 96,  207. (b) Wang, K. K.; Wang, Z.; Tarli, A. Gannett, P.  
      J. Am. Chem. Soc. 1996, 118, 10783. (c) Andemichael, Y. W.; Huang, Y.; Wang, K. K.; J.      
     Org. Chem. 1993, 58, 1651.
100
26. Ben-Efraim, D. A.; Sondheimer, F. Tetrahedron Lett. 1963, 313.
27. Bowes, C. M.; Montecalvo, D. F.; Sondheimer, F. Tetrahedron Lett. 1973,  3181.
28. Braverman, S.; Duar, Y. Tetrahedron Lett. 1978,  1493.
29. (a) Brinker, U. H.; Fleischhauer, I.  Angew. Chem., Int. Ed. Engl. 1979, 18, 396. (b)                 
     Okamura, W. H.; Peter, R.; Reischl, W. J. Am. Chem. Soc. 1985, 107, 1034. (c) Andemichael, 
     Y. W.; Wang, K. K.  J. Org. Chem. 1992, 57,  796. (d) Wang, K. K.; Zhang, Q.; Liao, J.           
     Tetrahedron Lett. 1996, 37, 4087.
30. (a) Hooz, J.; Mortimer, R. Tetrahedron Lett. 1976, 805. (b) Zweifel, G.; Backlund, S. J. J.       
      Organomet. Chem. 1978, 156, 159. (c) Wrackmeyer, B.; Bihlmayer, C.; Schilling, M. Chem.   
      Ber. 1983, 116, 3182. (d) Wang, K. K.; Chu, K. -H. J. Org. Chem. 1984, 49, 5175. (e) Chu,    
      K. -H.; Wang, K. K. J. Org. Chem. 1986, 51, 767. (f) Wang, K. K.; Chu, K. -H.; Lin, Y.;         
      Chen, J.-H Tetrahedron 1989, 45, 1105. (g) Wang, Z.; Wang, K. K. J. Org. Chem. 1994, 59,   
      4738. (h) Tarli, A.; Wang, K. K. J. Org. Chem. 1997, 62, 8841.  For reviews of chemistry of   
      organoborates, see: (i)   Vaultier, M.; Carboni, B. in: Abel, E. W.; Stone, F.G.A.; Wilkinson,  
      G. (Eds). Comprehensive Organometallic Chemistry II.  a Review of the Literature                  
      1982–1994, vol. 11, pp 227-229, Pergamon Press, Oxford, 1995. (j)  Negishi, E.-i. J.               
      Organomet. Chem. 1976, 108, 281.
31. (a) Johnson, F. Chem. Rev. 1968, 68, 375. (b) Hoffmann, R. W. Chem. Rev. 1989, 89, 1841.
32. Brown, H. C.; Sinclair, J. A. J. Organomet. Chem. 1977, 131, 163.
33. (a) Woodward, R. B.; Hoffmann, R. J. Am. Chem. Soc. 1965, 87, 395. (b) Okamura, W. H.;
      De Lera, A. R. in: Trost, B. M.; Fleming, I. (Eds). Comprehensive Organic Synthesis,              
      Pergamon Press, New York, 1991, vol.5, p. 699.
101
34. (a) Braverman, S.; Duar, Y.; Segev, D. Tetrahedron Lett. 1976, 3181. (b) Braverman, S.;         
      Segev, D. J. Am. Chem. Soc. 1974, 96, 1245.
35. Hopf, H.; Bohm, I.; Kleinschroth, J. Org. Syn. 1981, 60,  41.
36. Kramer, G.W.; Brown, H. C.; J. Organomet. Chem. 1974, 73, 1.
37. Skattebol, L. J. Org. Chem. 1966, 31, 2789.
38. Brandsma, L.; Verkruijsse, H. D. Synthesis of Acetylenes, Allenes and Cumulenes, Elsevier,    
      Amsterdam, 1981, p. 157.  
39. (a) Brown, H. C.; Khire, U. R.; Racherla, U. S. Tetrahedron Lett. 1993, 34, 15. (b) Brown, H. 
      C.; Khire, U. R.; Narla, G.; Racherla, U. S. J. Org. Chem. 1995, 60, 544.
40. Alcaide, B.; Luengo, J. I.; Fernandez, F.  An. Quim., Ser. C 1981, 77, 200.
41. For full reviews see: (a) Nicoloau, K. C.; Dai, W-M. Angew Chem., Int. Ed. Engl. 1991, 30,    
      1387-1416. (b) Maier, M. E. Synlett. 1995, 13-26.
42. (a) Jones, R. R.; Bergman, R. G. J. Am. Chem. Soc. 1972, 94, 660–661. (b) Lockhart, T. P.;     
      Comita, P. B.; Bergman, R. G. J. Am. Chem. Soc. 1981, 103, 4082–4090. (c) Bharucha, K.      
      N.; Marsh, R. M.; Minto, R. E.; Bergman, R. G. J. Am. Chem. Soc. 1992, 114, 3120–3121.      
     For recent reviews, see: (d)  Wang, K. K. Chem. Rev. 1996, 96, 207–222.  (e) Grissom, J. W.;  
     Gunawardena, G. U.; Klingberg, D.; Huang. D. Tetrahedron 1996, 52, 6453–6518. 
43. (a) Myers, A. G.; Kuo, E. Y.; Finney, N. S. J. Am. Chem. Soc. 1989, 111, 8057–8059. (b)        
      Myers, A. G.; Dragovich, P. S. J. Am. Chem. Soc. 1989, 111, 9130–9132.  (c) Nagata, R.;        
      Yamanaka, H.; Okazaki, E.; Saito, I. Tetrahedron Lett. 1989, 30, 4995–4998.  (d) Nagata, R.; 
      Yamanaka, H.; Murahashi, E.; Saito, I. Tetrahedron Lett. 1990, 31, 2907–2910. (e) Wang, K. 
      K.; Wang, Z.; Tarli, A.; Gannett, P. J. Am. Chem. Soc. 1996, 118, 10783–10791 and                
102
      references cited therein. (f) Grissom, J. W.; Klingberg, D.; Huang, D.; Slattery, B. J. J. Org.    
      Chem. 1997, 62, 603–626 and references cited therein.
44. (a) Moore, H. W.; Yerxa, B. R. Chemtracts 1992, 273–313. (b) Tarli, A.; Wang, K. K. J.         
      Org. Chem. 1997, 62, 8841–8847. 
45. (a) David, W. M.; Kerwin, S. M. J. Am. Chem. Soc. 1997, 119, 1464–1465. (b) Hoffner, J.;     
      Schottelius, M. J.; Feichtinger, D.; Chen, P. J. Am. Chem. Soc. 1998, 120, 376–385. (c)           
      Braverman, S.; Duar, Y.; Freund, M. Isr. J. Chem. 1985, 26, 108–114.
46. Shi, C.; Wang, K. K. J. Org. Chem. 1998, 63, 3517–3520.
47. (a) Maier, M. E. Synlett 1995, 13–26. (b) Nicolaou, K. C.; Dai, W.-H. Angew. Chem., Int. Ed. 
      Engl. 1991, 30, 1387–1416.
48 (a) Differding, E.; Ghosez, L. Tetrahedron Lett. 1985, 26, 1647–1650. (b) Molina, P.;               
      Alajarín, M.; Vidal, A.; Sánchez-Andrada, P. J. Org. Chem. 1992, 57, 929–939.
49. Gillmann, T.; Hulsen, T.; Massa, W.; Wocadlo, S. Synlett 1995, 1257–1259.
50. Wilt, J. W.; Aznavoorian, P. M. J. Org. Chem. 1978, 43, 1285–1286.
51. Schmittel, M.; Steffen, J.-P.; Angel, M. A. W.; Engels, B.; Lennartz, C.; Hanrath, M. Angew.  
      Chem., Int. Ed. Engl. 1998, 37, 1562–1564.      
52. (a) Schmittel, M.; Steffen, J.-P.; Auer, D.; Maywald, M. Tetrahedron Lett. 1997, 38,                
      6177–6180. (b) Schmittel, M.; Strittmatter, M.; Kiau, S. Angew. Chem., Int. Ed. Engl. 1996,   
      35, 1843–1845. (c) Schmittel, M.; Kiau, S.; Siebert, T.; Strittmatter, M. Tetrahedron Lett.       
      1996, 37, 7691–7694. (d) Schmittel, M.; Strittmatter, M.; Vollmann, K.; Kiau, S.                     
      Tetrahedron Lett. 1996, 37, 999–1002. (e) Schmittel, M.; Maywald, M.; Strittmatter, M.         
      Synlett 1997, 165–166. (f) Schmittel, M.; Strittmatter, M.; Kiau, S. Tetrahedron Lett. 1995,    
103
      36, 4975–4978. (g) Garcia, J. G.; Ramos, B.; Pratt, L. M.; Rodriguez, A. Tetrahedron Lett.     
      1995, 36, 7391–7394.
53. Foland, L. D.; Karlsson, J. O.; Perri, S. T.; Schwabe, R.; Xu, S. L.; Patil, S.; Moore, H. W. J.  
      Am. Chem. Soc. 1989, 111, 975–989.
54. (a) Molina, P.; Alajarín, M.; Vidal, A. J. Chem. Soc., Chem. Commun. 1990, 1277–1279. (b)  
     Saito, T.; Ohmori, H.; Furuno, E.; Motoki, S. J. Chem. Soc., Chem. Commun. 1992, 22–24.      
     (c) Saito, T.; Ohmori, H.; Ohkubo, T.; Motoki, S. J. Chem. Soc., Chem. Commun. 1993,           
     1802–1803.
55. (a) Peczyska-Czoch, W.; Pognan, F.; Kaczmarek, L.; Boratyski, J. J. Med. Chem. 1994, 37, 
      3503–3510. (b) Kaczmarek, L.; Balicki, R.; Nantka-Namirski, P.; Peczyska-Czoch, W.;         
      Mordarski, M. Arch. Pharm. (Weinheim) 1988, 321, 463–467. 
56. After the original manuscript had been submitted for publication, a similar study was               
      reported:  Schmittel, M.; Steffen, J.–P.; Engels, B.; Lennartz, C.; Hanrath, M. Angew. Chem., 
      Int. Ed. Engl. 1998, 37, 2371–2373.
57. Shi, C.; Zhang, Q.; Wang, K. K. J. Org. Chem. 1999, 64, 925.
58. This work was finished by Chongsheng Shi in our group.
59. Alajarín, M.; Molina, P.; Vidal, A. J. Nat. Prod. 1997, 60, 747–748.
60. (a) Sharaf, M. H. M.; Schiff, P. L., Jr.; Tackie, A. N.; Phoebe, C. H., Jr.; Martin, G. E. J.         
      Heterocycl. Chem. 1996, 33, 239–243. (b) Cimanga, K.; De Bruyne, T.; Pieters, L.; Claeys,     
      M.; Vlietinck, A. Tetrahedron Lett. 1996, 37, 1703–1706.
61. (a) Shioiri, T.; Ninomiya, K.; Yamada, S.-i. J. Am. Chem. Soc. 1972, 94, 6203–6205. (b)         
      Ninomiya, K.; Shioiri, T.; Yamada, S. Tetrahedron 1974, 30, 2151–2157. (c) Rigby, J. H.;      
104
      Balasubramanian, N. J. Org. Chem. 1989, 54, 224–228.
62. Horner, L.; Oediger, H. Justus Liebigs Ann. Chem. 1959, 627, 142–162.
63. Gribble, G. W.; Saulnier, M. G. J. Chem. Soc., Chem. Commun. 1984, 168–169.
64. (a) Armstrong, R. N.; Ammon, H. L.; Darnow, J. N. J. Am. Chem. Soc. 1987, 109,                   
      2077–2082. (b) Newman, M. S.; Hussey, A. S. J. Am. Chem. Soc. 1947, 69, 3023–3027. 
65. (a) Pindur, U.; Erfanian-Abdoust, H. Liebigs Ann. Chem. 1988, 803–805. (b) Pindur, U.;         
      Erfanian-Abdoust, H. Chem. Rev. 1989, 89, 1681–1689.
66. (a) Villemin, D.; Goussu, D. Heterocycles, 1989, 29, 1255–1261. (b) Arcadi, A.; Cacchi, S.;   
      Marinelli, F. Tetrahedron Lett. 1989, 30, 2581–2584. (c) Iritani, K.; Matsubara, S.; Utimoto.   
      K. Tetrahedron Lett. 1988, 29, 1799–1802.
67. For reviews of the synthesis and biological activity of pyridocarbazoles and related                  
      compounds, see: (a) Gribble, G. W. The alkaloids; Brossi, A., Ed.; Academic: New York,       
      1990; Vol. 39, p1. (b) Bergman, J.; Pelcman, B. Tetrahedron 1988, 44, 5215. (c) Kansal, V.    
      K.; Potier, P. Tetrahedron 1986, 42, 2389. (d) Gribble, G. W.; Saulnier, M. G. Heterocycles    
      1985, 23, 1277. (e) Sainsbury, M. Synthesis 1977, 437.
68.  Goodin, S.; Smith, A. F.; Horning, E. C. J. Am. Chem. Soc. 1959, 81, 1903.
69.  Daton, L. K.; Demerac, S.; Elmes, B. C.; Loder, J. W.; Swan, J. M; Tertei, T. Aust. J. Chem.  
       1967, 20, 2715.
70. Kansal, V. K.; Potier, P. Tetrahddron, 1986, 40, 2389
71. (a) Rouesse, J.; Spielmann, M.; Turpin, F.; Lechevalier, T.; Azab, M.; Mondesir, J. M. Phase  
      II study of Ellipticine Acetate Salvage Treatment of Advanced Breast Cancer. Eur. J. Cancer.
      1993, 29, 856. (b) Jurayj, J.; Haugwitz, R. D.; Varma, R. K.; Paull, K. D. ; Barrett, J. B.;         
105
      Cushman, M. J. Med. Chem. 1994, 37, 2190.
72. Acton, E.M.; Narayanan, V. L.; Cushman, M.; Haugwitz, R. D.; Risbood, P.; Monks, A.;        
      Scudiero, D.; Shoemaker, R. H.; Boyd, M. R. Anticancer Specificity of Some Ellipticinium     
      Salt against Human Brain Tumors in virto.  In Proceedings of the Eighty-Third Annual            
     Meeting of the American Association for Cancer Research: San Diego, California, 1992; pp     
     488, Abstract Number 2917.
73. Aderson, W. K.; Gopalsamy, A.; Redely, P. S.; J. Med. Chem. 1994, 37, 1955.
74. Shi, L. M.; Fan, Y.; Myers, T. G.; O’Connor, P. M.; Paull, K. D. ; Friend, S. H. ; Weinstein,    
      J. N. J. Chem. Inf. Comput. Sci. 1998, 38, 189.
75. Davraj, R.; Barret, J. F.; Fernadez, J. A.; Katzenellenbogen, J. A.; Cushman, M. J. Med.          
      Chem. 1996, 39, 3367
76. Woodword, R. B.; Lacobucii, G. A.; Hochstein, F. A. J. Am. Chem. Soc. 1960, 82, 1142
77. Miller, R. B.; Dugar, B.  Tetrahedron Lett. 1989, 30, 297
78. (a) Rivalle, C.; Ducrocq, C.; Bisagni, E. J. Chem. Soc., Perkin Trans. 1, 1979, 138. (b)            
      Ducrosq, C.; Bisagni, E.; Lhoste, J. M. J. Chem. Soc., Perkin Trans. 1, 1979, 142. (c) Rivalle, 
      C.; Ducocq, C.; Bisagni, E. J. Org. Chem. 1980, 45, 2176
79. Bergman, J.; Carlson, R. Tetrahedron Lett. 1977, 4663.
80. May, C.; Moody, C. J. J. Chem. Soc., Chem. Commun. 1984, 926.
81. Gribble, G.W.; Saulnier, M.G.; Obaza-Nutaitis, J. A.; Ketcha, D. M. J. Org. Chem, 1992, 57,  
      5891.
82. Niki, y.; Tada, Y.; Yanase, N.; Hachiken, H.; Matsushita, K. Tetrahedron Lett. 1996, 37,         
      7753.
106
83. Komonova, V. V.; Semenov, A. A. Khim. Geterotsikl. Soedin. 1982, 1211
84. Granwell, P. A.; Saxton, J. E. J. Chem. Soc. 1962, 3842.
85. Ergun, Y.; Patir, S.; Okay, G. J. Heterocyclic. Chem. 1998. 35, 1445.
86. Dharmasena, P. M.; Shannon, P. V. R.; Tetrahedron Lett. 1994, 35, 7119.
87. Eckert, H.; Forster, B. Angew. Chem., Int. Ed. Engl. 1987, 26, 894.
107
APPENDIX
108
Publications Related to This Dissertation
1.  “A Novel and Efficient Synthesis of 5-Aza Analogues of Ellipticine” Quan Zhang, Chongshen 
     Shi and Kung K. Wang (manuscript in preparation for Journal of Organic Chemistry. 1999, as 
     a full paper).
2.  “Biradicals from Thermolysis of N-[2-(1-Alkynyl)phenyl]-N-phenylcarbodiimides and Their   
     Subsequent Transformations to 6H-Indolo[2,3-b]quinolines” Chongshen Shi, Quan Zhang       
     and Kung K. Wang. Journal of Organic Chemistry. 1999, 64, 925.
3. “Generation of o-Quinodimethanes via the Electrocyclic Reaction of (4Z)-1,2,4,6,7-                  
     Octapentaenes Derived from the Organoborate Complexes and their Subsequent Reactions”     
     Quan Zhang and Kung K. Wang. A special issue of the Journal of Organometallic Chemistry  
      with the theme Boron Chemistry at the Millennium (in press, 1999, as a full paper).
4. “Synthesis of 5-Methylene-1,3-cyclohexadienes (o-Isotoluenes) via Electrocyclization of (4Z)-  
      1,2,4,6-Heptatetraenes” Kung K. Wang, Quan Zhang and Junkai Liao. Tetrahedron Lett.         
    1996, 37, 4087.
5. “Biradicals from Thermolysis of N-[2-(1-Alkynyl)-N-phenylcarbodiimides and Subsequent      
    Transformations to 2-(Phenylamino)quinolines and 6H-Indolo[2,3-b]quinolines” Chongshen     
    Shi, Quan Zhang and Kung K. Wang. Presented at the 216th National Meeting of the                
    American Chemical Society, ORGN584, Boston, MA, 1998.
6. “Preparation and Reactions of o-Quinodimethanes via Electrocyclization of (Z)-1,2,4,6,7-         
    Octapentaenes Derived from Organoborate” Kung K. Wang and Quan Zhang. Presented at      
    the 215th National Meeting of the American Chemical Society, ORGN306, Dallas, TX,  1998.
